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Abstract
Here I will focus on three main topics that best address and include the projects I have been
working in during my three year PhD period that I have spent in different research laboratories
addressing both computationally and practically important problems all related to modern
molecular genomics.
The first topic is the use of livestock species (pigs) as a model of obesity, a complex hu-
man dysfunction. My efforts here concern the detection and annotation of Single Nucleotide
Polymorphisms. I developed a pipeline for mining human and porcine sequences. Starting from
a set of human genes related with obesity the platform returns a list of annotated porcine
SNPs extracted from a new set of potential obesity-genes. 565 of these SNPs were analyzed on
an Illumina chip to test the involvement in obesity on a population composed by more than
500 pigs. Results will be discussed. All the computational analysis and experiments were done
in collaboration with the Biocomputing group and Dr.Luca Fontanesi, respectively, under the
direction of prof. Rita Casadio at the Bologna University, Italy.
The second topic concerns developing a methodology, based on Factor Analysis, to simul-
taneously mine information from different levels of biological organization. With specific test
cases we develop models of the complexity of the mRNA-miRNA molecular interaction in brain
tumors measured indirectly by microarray and quantitative PCR. This work was done under
the supervision of Prof. Christine Nardini, at the “CAS-MPG Partner Institute for Compu-
tational Biology” of Shangai, China (co-founded by the Max Planck Society and the Chinese
Academy of Sciences jointly)
The third topic concerns the development of a new method to overcome the variety of
PCR technologies routinely adopted to characterize unknown flanking DNA regions of a viral
integration locus of the human genome after clinical gene therapy. This new method is entirely
based on next generation sequencing and it reduces the time required to detect insertion sites,
decreasing the complexity of the procedure. This work was done in collaboration with the
group of Dr. Manfred Schmidt at the Nationales Centrum für Tumorerkrankungen (Heidelberg,
Germany) supervised by Dr. Annette Deichmann and Dr. Ali Nowrouzi.
Furthermore I add as an Appendix the description of a R package for gene network recon-
struction that I helped to develop for scientific usage (http://www.bioconductor.org/help/
bioc-views/release/bioc/html/BUS.html).
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Chapter 1
Introduction
1.1 Obesity
Obesity is a pandemic, complex and multifactorial disease. It predispose to morbidity as type 2
diabetes, heart disease and hypertension with the consequence of premature mortality. Obesity
is common all over the world where an obesogenic environment is created and where sedentary
lifestyle and high energy intake are encouraged. Although this trend of increasing body fat is
driven by the obesogenic environment, it is facilitated by the individual’s genetic susceptibility
to excessive weight gain.
This disorder is highly heritable and studies in twins, adoptees and families shows that
80% of the variance in the body mass index (BMI) is attributable to genetic factors. Relative
risk of obesity among siblings was estimated to be 3 to 7 [AFN96], the concordance rate of
obesity is higher between monozygotic twins than dizygotic twins [MNE97, SFH86, AKK+96],
and adoptees’ weight is often closer to their biological parents than their adoptive parents
[SSH+86]. These studies supported the role of genes in the pathogenesis of human obesity.
Obesity gene research has advanced rapidly over the past 2 decades, which has provided rev-
elation of the molecular mechanism of energy homeostasis in the process. Traditional methods
employed to uncover these obesity genes include genome-wide scans which studied unrelated
obese individuals, linkage studies which examined related pairs or families with obesity, and
association studies which investigated the association between obesity and polymorphic vari-
ants of candidate genes predicted to affect weight regulation. Differently from how they worked
for other multifactorial disorders, these approaches have not been as promising for common
obesity, because the obese phenotype is very heterogeneous, even within the same family.
The progress in computers and technologies such as high throughput sequencing machines
have made it possible to analyse combinations of multiple SNPs or haplotypes in candidate
genes related to weight regulation. A new approach to identify genes affecting weight regulation
is to study individuals who are thin and have difficulty gaining weight (obesity resistance)
[LKM+83, FO06] because like obesity, leanness is heritable and it is therefore conceivable that
studies of the reverse phenotype can complement the efforts to uncover the obesity genes.
1.1.1 Obesity and livestock genomes
The human genome sequencing project had high impact on the animal genetic research and the
complete genome sequences of several livestock species are now available. A basic underlying
hypothesis of comparative genomics is that evolutionarily conserved sequences are functionally
important. Based on this hypothesis, biologic experimentation has focused on sequences that
are highly conserved among vertebrate species. Clues in elucidating molecular mechanisms
and pathways involved in disorders can be obtained with animal models, in which genetic
experimental manipulation is allowed [BGK08]. Depending on the disorder type, non-rodent
animal models have been described as the better ones. The pig (Sus scrofa) in relation with
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dimensions, physiology and genetics is considered a better in vivo model for obesity than other
animal models like mouse and rat [SG08, BZ09]. Genetic maps of livestock genomes have
been applied in several linkage studies to map loci and genes that underlie genetic variance of
economically important traits. In pig production, fatness is an important trait that has been
extensively studied over the last years.
1.1.2 Fatness regulation traits in pigs
Pigs have been intensively used as a biomedical research model for various human physiological
conditions [TS96], and pigs and humans share numerous physiological and phenotypic similari-
ties for fat deposition and food intake [HHP79]. Therefore, identified chromosomal regions and
genes that regulate lean growth and fat deposition in pigs might be helpful to study the genetic
basis of human obesity and other related health problems.
In pig production the two depots of highest interest are back fat (which accounts for 60-
70% of total body fat) and intramuscular fat (IMF). In breeding programs, selection is directed
against back fat thickness (BFT), because reduced carcass fatness benefits carcass quality and
production efficiency. Over the years breeding has resulted in reduced back fat thickness (from
3.2 to 1.9 mm) and increased loin muscle area (40 to 60 cm2) which indicates high genetic
determination of these body composition traits [RPK03]. With the use of molecular genetic
methods, such as candidate gene and genome scan approaches, the identification of genes for
obesity and growth can be obtained. In Sus scrofa, candidate genes associated with obesity
and growth include Leptin Receptor, Melanocortin-4 Receptor, Agouti related protein, Heart
fatty acid binding protein 3, and Insulin-like growth factor 2. Some of these candidate genes
also explain the variation in obesity levels in humans [RPK03].
In human obesity body fat is accumulated in four different depots in the body: subcuta-
neous, visceral, intermuscular and intramuscular [CCT99]. Identification of genes involved in fat
development in pigs could lead to a better understanding of the underlying genetic mechanisms
in pigs and, by projection, in humans.
1.1.3 Quantitative trait loci for complex traits
The candidate gene approach applies previous knowledge about the functions of genes to select
those genes that might be involved in the trait of interest. The selected candidate genes are
tested for association with the trait or phenotype. The candidate gene approach has particularly
been successful for relatively simple traits with only few genes involved, like the identification of
genes involved in coat color in pigs [KWT+98, KMPA01]. In the whole genome scan approach,
a large number of genetic markers from across the genome is analysed to observe segregation of
chromosomal segments through a pedigree. By analyzing the (co-)segregation of the phenotypic
trait or value with certain chromosomal segments in an experimental population, chromosomal
regions harboring genes affecting a quantitative trait can be identified ([Gel96]. Such a chro-
mosomal region harboring genes that influence the variation of a quantitative trait is referred
to as a quantitative trait locus (QTL). In general, experimental populations for QTL mapping
are comprised of intercrosses of phenotypically divergent founder populations. The assumption
that the genes influencing the trait of interest are fixed in these founder populations enables
identification of QTL regions explaining the genetic differences among populations. For most
detected QTL, the identified chromosomal regions are still large and harbor hundreds of genes.
To narrow down these regions to the gene(s) or eventually the mutation causing the effect on the
phenotype, fine-mapping of this region is necessary. Fine-mapping can be achieved by adding
markers in the region, and/or by applying additional approaches like linkage disequilibrium
mapping (LD) and haplotype-sharing analysis.
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Table 1.1. SNPs categories: transitions (2 ) and transversion (1 )
1.1.4 Single nucleotide polymorphisms
According to Brookes [Gel96, Bro99], the definition of a single nucleotide polymorphism is a
single base pair position in genomic DNA at which different sequence alternatives (alleles) exist
in normal individuals in some population(s), and where the less frequent allele has an abun-
dance of 1% or greater. This definition is rather strict, as it holds some factors that exclude
polymorphisms based on the allele frequencies in the population studied. In addition, inser-
tion/deletion polymorphisms (indels) are excluded, since they are created through a different
mechanism and do not have an alternative nucleotide on the polymorphic position. In practice,
all subtle sequence differences, including indels, are potential markers for mapping purposes,
even those with low frequencies. In addition, the frequency is dependent on the studied popu-
lation. Consequently, a polymorphism might be a true SNP in one population and just a subtle
DNA difference in another. Altogether, it is neither practical nor useful to classify all subtle
DNA differences as either true SNPs or indels or ‘low’ frequency polymorphisms. Most polymor-
phisms can be used for the same goal, using the same methods, regardless of allele frequencies,
population or origin of the mutation. For these reasons, in this thesis a wide definition of SNPs
is applied and all point mutations are considered SNPs, as is commonly done in practice. SNPs
are predominantly bi-allelic, even though in principle any of the four nucleotides can be present
at any position in a stretch of DNA. This is due to the low frequency of mutations that leads
to new SNPs. This mutation rate is estimated at 10−8 changes per nucleotide per generation
and corresponds to about 100 new SNPs per individual. As a result, the chance for a second
independent mutation that introduces a third allele at the same position is very low (10−16,
about 1 second independent mutation per 106 individuals ).
Basically, the bi-allelic SNPs are comprised of two different categories: transitions and
transversions (see table 1.1). In transitions, a purine is exchanged for the other purine, while on
the reverse strand a pyrimidine is exchanged for the other pyrimidine. Transversions consist of
purine-pyrimidine (and their complementary pyrimidine-purine) exchanges. The occurrences
of transitions and transversions are not equal in the genome. Although there are two times
as many options for transversions as for transitions, transitions are found twice as often as
transversions. The higher level of transitions might be related to 5- methylcytosine (5mC)
deamination reactions. 5mC is the product of post-synthetic modification of cytosine residues
and occurs primarily in CpG doublets in the mammalian genome. 5mC is a mutable site that
can undergo spontaneous deamination to thymine. Although a repair mechanism specifically
recognizes G-T mismatches and replaces the thymine with cytosine, the 5mC to T transition
mutation occurs about 10 times more often than other transitions [HG93].
The rate at which nucleotide differences are observed between two randomly chosen chro-
mosomes is called the nucleotide diversity index (Nei1979). In the human genome, this index
is estimated at one in a thousand basepairs [LS91]. Screening more chromosomes (more indi-
viduals) will identify more polymorphisms, but the nucleotide diversity index remains constant
and allows comparisons among studies applying different sample sizes. Compared to the to-
tal human genome, the nucleotide diversity index in coding regions is about 4-fold lower and
about half of these coding mutations result in non-synonymous codon changes [LS91]. Nu-
cleotide diversity indexes are reported to be 1/1331 bp in humans [SWS+01], 1/515 bp in mice
[LTWD+00] and 1/609 bp in pigs [FFS+02]. Overall, this adds up to about several millions of
SNPs between any two individuals and about 100,000 amino acid changes in the proteomes. It
has been estimated that in the world’s human population, about 10 million SNPs (that is, 1
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Fig. 1.1. Delivery system. A: schematic view of the delivery process mediated by liposomes; the exogenous
material provided by the liposome enters (transiently) in the nucleus as episomic DNA. B: delivery process
provided by retrovirus;
variant site per 300 bases on average) vary such that both alleles are observed at a frequency
of 1% or greater, and that these 10 million common SNPs constitute 90 % of the variation
in the population [RGA03]. I will use this last SNP frequencies estimation as a parameter to
discriminate SNPs that arise from noise (paralogues, pseudogenes).
1.2 Insertion sites in gene therapy
1.2.1 Gene therapy
The major goal of gene therapy is to introduce a functional gene into a target cell and restore
protein production that is absent or deficient due to a genetic disorder. Gene transfer has
been successfully used to treat a wide spectra of genetic diseases like X-linked severe-combined
immunodeficiency (SCID-X1), ß-thalassemia, adenosine deaminase deficiency, chronic granulo-
matous disease and more recently adrenoleukodystrophy [CHBAB+09].
This is a technique whereby the loss of function due to a faulty gene is restored by a working
gene introduced in the host using a gene transfer strategy.
1.2.2 Gene transfer strategies
Over the years two categories of gene transfer vehicles have been developed: synthetic and
virus-based gene delivery systems (see Figure 1.1) .
Synthetic system Synthetic gene delivery systems depend on direct delivery of genetic infor-
mation into a target cell and include: a) direct injection of naked DNA and b) encapsulation
of DNA with cationic lipids (Figure 1.2). These delivery systems exhibit low toxicity but gene
transfer is in general inefficient and often transient. For those reasons this group of delivery
systems is employed to the delivery of drugs or to transiently transfect with DNA or RNA
naked cells.
1.2 Insertion sites in gene therapy 7
Fig. 1.2. A liposome
Fig. 1.3. Nonreplicating virus particles containing the genetic information of a therapeutic gene. GAG, POL and
ENV viral structural genes; S, Packaging signal; LTR, Long Terminal Repeats; RRE, rev responsive element.
Virus-based system Viral delivery systems are based on replicating viruses that have the ability
to deliver genetic information into the host cell. As shown in Figure 1.3in general, genomes of
replicating viruses contain two kinds of sequences: 1) coding regions and 2) cis-acting regula-
tory elements. The first sequences enclose the genetic information of the viral structural and
regulatory proteins required for propagation of infectious viruses, whereas cis-acting sequences
are essential for packaging of viral genomes and integration into the host cell. In a replication-
defective viral vector, the coding regions of the virus are not functional and could be deleted
and replaced by the genetic information of a therapeutic gene, leaving the cis-acting sequences
intact (figure 1.3).
Viral vectors currently available for gene therapy are based on different viruses and can
roughly be categorized into: 1) vectors that have the ability to integrate their viral genome into
the chromosomal DNA of the host cell (adeno-associated virus and retroviruses); 2) vectors
that deliver their genomes into the nucleus of the host cell, remaining episomal (adenovirus
and herpes simplex virus type 1).
1.2.3 Insertion sites
While most if the delivery systems adopted in gene therapy are based on integrating viruses,
the positive clinical outcomes are balanced by events that could drive the patients to adverse
consequences. It has been showed that the integration of the viral genome could increase the
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transcription of cancer-related genes and the probability of developing leukemia [HBAVKS+03a,
HBAvKS+03b].
Due to the adverse integration event, a strong interest has been aroused in order to follow
the fate of the gene-corrected cells, monitor eventual adverse consequences and aid researchers
and physicians to develop new strategies in gene therapy. The analysis of the insertional profile
of the vectors is a tool used to verify the “safety” of the gene therapy approach in patients.
1.2.4 LAM-PCR
Different technologies are developed to detect the flanking regions of viral insertion sites in
which polymerase chain reaction (PCR) is the base: LM-PCR [MW89], LAM-PCR [SSB+07]
and nrLAM-PCR [GEP+09]. The last two methods have the advantage to be sufficiently sen-
sitive, specific and robust. Besides the analysis of the insertions sites could be conducted on
complex samples with multiple integration sites and starting from a minimal amount of mate-
rial. On the contrary some disadvantages are affecting such techniques like:
• bias due to the use of restriction enzymes [WBM+10] where some sites could remain
undiscovered
• the complexity of the techniques in which several steps are required to achieve the results.
1.3 Next generation sequencing
1.3.1 Sequencing technologies
1.3.1.1 Maxam-Gilbert sequencing It was the first powerful method developed in 1977
[MG77] for sequencing DNA molecules. It is based on a chemical digestion where a DNA chain
is digested by chemical reagents that cut uniformly at the level of one nucleotide. In this method
the DNA chains are marked at the 5’ end by 32P using a polinucleotide kinase. See figure 1.4
for details. This method was replaced by the chain-termination method.
1.3.1.2 Sanger sequencing The chain-termination method was published by Frederick
Sanger in the same year [SNC77]. This methods is based on the controlled interruption of
the enzymatic replication of the DNA. The DNA pol I is used for copying a single strand DNA
chain starting from complementary fragments. If in the incubation mix are present, in addition
to the four standard deoxynucleotides (dATP, dGTP, dCTP and dTTP), four 2’,3’ dideoxy
analogs, the incorporation of an analog stops the synthesis with the result of the production of
4 populations of fragments having different length. If the four deoxynucleotides are marked ra-
dioactively an auto-radiography of an electrophoresis run could reveal the chain DNA sequence
(see figure 1.5). Technical modifications in the procedure with the introduction of fluorescent
terminator dyes, the use of optical systems and the availability of computers explain why Sanger
method became at the end of the ’80s the standard procedure in sequencing projects.
1.3.1.3 High-throughput sequencing After the completion of the human genome sequenc-
ing in 2003 the industry released sequencing technologies that produce millions of sequences in
one run at a fraction of the cost necessary in the pre-high-throughput “era”. Here I will describe
the most used.
454 sequencing This system is based on pyrosequencing [RKP+96], in which single strand
DNA chains are immobilized onto beads and amplified by PCR in order to have a clonal
colony per bead. Then beads are placed into a small camera (~29µm) in the PicoTiterPlate via
controlled process that attempts to deposit one bead per well. In the weel the pyrosequencing
process is made adding luciferase and other components that generate light when a nucleotide
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Fig. 1.4. Schematic diagram of the Maxam-Gilbert procedure. On the right the gel with the radioactive frag-
ments after the specific cut of the sequence AGTGTCAT in each bases (A, C, G and T). Following the gray
arrows the sequence is obtained.
Fig. 1.5. Sanger procedure. Fragments are produced adding analogues of dideoxy nucleotides (red) in the
polymerization mix. In the example the reaction returns 7 different fragments.
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Fig. 1.6. Color space scheme in SOLID system.
is incorporated during the synthesis. The light is transferred via optic fiber (embedded in
the PicoTiterPlate) to a CCD camera controlled by the software and that stores data in a
binary proprietary format called Standard Flow-gram Format (SFF). This technology is able
to sequence more than 1 million reads with more than 400 bases each.
Illumina (Solexa) sequencing The Illumina sequencing (previously called Solexa) is a method
that uses reversible dye terminators. The idea is to attach the DNA molecules to synthetic
primers on a chip and then to amplify locally the fragments in order to obtain a local clonal
colony. The sequencing is done by cycles and for each cycle modified ddNTPs are added. A
CCD takes the images of the fluorescent labeled nucleotides and the blocker at the 3’ end of
the dye is chemically removed from DNA. Performances of this system are hundred millions of
100 bases length reads in a week.
SOLiD sequencing This is the last technology released in the market (2007) and it is based
on a new sequencing technology called (by SOLID) 2 Base Encoding. As for the other two
technologies the DNA chains are isolated and then amplified locally in a weel. Then the SOLiD
procedure is based on sequencing by ligation of specific 8-mer probes in which only the first two
bases (starting at the 3’ end) are complementary to the nucleotides being sequenced whereas the
other 6 are degeneres. The procedure is based on an “external” cycle composed by m internal
reactions. Refer to figure for details. I want to underline that in this procedure the fluorescence
is related to the composition of a dinucleotide and that each base is interrogated two times.
This points to a “new” sequence space called color space where each sequence expressed in this
code needs to be decoded. The decoding step requires 1) to know which is the first base of the
sequence and 2) a table that associate each color to a dinucleotide. The color scheme is the
symmetry group of a rectangle (Klein four-group; Figure 1.6). It is interesting to point out that
this code is useful to discriminate between sequence variation (SNPs) and sequencing errors.
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Fig. 1.7. miRNA biosynthesis. The primary transcript is processed by DROSHA into the harpin pre-miRNA.
Then the fragment is exported to the cytoplasm and cleaved by another RNAse DICER into a duplex. The
guide strand of the duplex binds with the miRNA induced silencing complex (miRISC) and then to the target
mRNA. This results in transcriptional repression, degradation or sequestration of the target gene function.
1.4 miRNA and mRNA interaction
It has been discovered that the genomes of organisms contain hundreds of small non coding
genes called microRNA (miRNA). miRNA are single-stranded RNA molecules of 21-23 nu-
cleotides in length transcribed by RNA polymerase II. Primary transcripts are not translated
into protein but are processed into hairpins by the RNAse enzyme Drosha, and exported
into the cytoplasm, where they are cleaved by the central enzyme of the RNAi pathway,
Dicer, to form single-stranded mature microRNAs [Amb04, Bar04]. Mature molecules have
the function to downregulate actively gene expression via base-paring to the target transcripts
[KHS09, WSGL07] (see Figure 1.7).
Plant microRNAs were recognized to function through near-perfect base pairing with their
targets [LXKC02, TRBZ03] in the coding region and regulate the amount of transcribed protein
via mRNA degradation [Wil08]. In animals, mature microRNAs bind to an imperfectly matched
binding site in the mRNAs of target genes and regulate their post-transcriptional expression. In
all known cases microRNAs repress expression of target genes, mostly by repressing translation
while not affecting the mRNA concentration of the target, and less often by directly inducing
a decrease in target mRNA concentrations[NMB+03].
1.4.1 miRNA mRNA association
The description of miRNA function depends on the target mRNAs and on the biological pro-
cesses in which they are involved. The signal between these two level and that implement the
miRNA cell function is poorly understood. A way to disentangle and understand correlative
changes in miRNA expression and biological functions is to 1) follow reductions in the level
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of a target protein (and by a potentially wrong assumption in animals reduction in target
mRNA), 2) infer subsequent effects that may alter the levels of other mRNAs and 3) follow
the ramification through the transcriptional profile to a whole biological process.
The first step is critical because in animals the regulated protein concentration is unrelated
with the corresponding mRNA concentration. In the last several years, a number of different
miRNA profiling strategies have been used for following the miRNA expression changes in
different processes like differentiation, apoptosis, cell proliferation and a range of diseases. In
this way it is possible to link directly miRNA expression with biological complex phenomena .
The most important strategies used are:
• Mirna Q-RT-PCR Profiling; a standard RT protocol is applied on a RNA sample and
miRNA specific primers will probe for a specific miRNA through PCR amplification. This
protocol is useful for a limited amount of RNA such as needle biopsies.
• Array Platform; probes for miRNA are spotted or synthesized on a chip. This has the
disadvantages to require high amount of RNA.
• Bead Based Method; it requires flow-cytometry where beads with specific miRNA probes
are attached and a mixture of two fluorescent dyes is used for coding uniquely the bead.
After these technical innovations, complex analysis in whole RNA permits the detection of
microRNA signal correlating miRNA and mRNA profiles [LPP+07, WL09, FCC+09].
Chapter 2
Methods
2.1 High dimensional molecular data (HDMD)
High throughput technologies, like microarray, genome sequencing and proteomics, are generat-
ing large amounts of high dimensional data that have to be analyzed and understood. Properties
of high dimensional data can affect the ability of statistical methods to extract meaningful in-
formation. For genomic and proteomic analyses, these properties reflect both statistical and
mathematical features of high dimensional data spaces.
2.1.1 Some statistical aspects of HDMD
Usually many more data points than sampling units (p n) HDMD typically has many more
data points (D = number of variables or dimensions) than sampling units (n). Classical mul-
tivariate statistics were mostly based on assumption that D is fixed and sample size n > D
or even n → ∞. Recent technological advances have generated much high dimensional bio-
logical data where D  n. Many multivariate statistical methods are impractical, fail, or are
computationally not feasible when D > n. Multivariate statistics typically involves operations
on a covariance matrix. When D > n, the covariance matrix is typically ill-conditioned, i.e.,
it is “singular” and does not have an inverse. Many statistical procedures, e.g., ML, can not
proceed when singularity occurs. It is possible to use a generalized inverse in calculations but
the ramifications of this are complex.
Meaningful replication is rare Replication is the repetition of the basic experiment. It is nec-
essary to estimate the error variance and obtain a precise estimate of the effects of interest.
Without replication, estimation of sample statistics is unstable, inaccurate and variation levels
(technical, biological, environmental) within samples remains unknown. An example, evolution-
ary models depend on the understanding of the extent of intrinsic genetic variation in a sample;
natural selection requires genetic variation to operate. Is the variation observed “biological?”
Initial data collection not hypothesis driven The search for critical variables to test hypothesis
is complicated by presence of many irrelevant variables. The problem becomes how to separate
critical variables from a vast pile of glut. This process introduces many complexities. Post hoc
variable selection can be difficult. In designed experiments, it is assumed that the researcher is
dealing with a few well-chosen variables. That is, scientific knowledge is being used to measure
the right variables in advance.
Dimensionality of information unknown Gene expression data typically consist of a measure-
ment of the (relative) expression level registered for a spot in correspondence to a particular
hybridization. Formally, then, we have the matrix
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Fig. 2.1. Course of dimensionality. S1, S2 and S3 are three experimental points projected in 2 (GeneA,GeneB)
and 3 (GeneA,GeneB,GeneC) dimensional spaces. In 2D the distance d(S1, S2) = D′ is smaller than the distance
d(S1, S3) = D′′ whereas in 3D the two distances become equal.
X =

x11 x12 . . . x1m
x21 x22 · · · x2m
...
... . . .
...
xn1 xn2 . . . xnm

where the element xij is the measured expression for spot i in hybridization j. We will assume
that there is one row per gene and one column per different experimental condition, e.g.,
tumor type or cell cycle phase. The data matrix X has n rows and d columns. In classical
statistical paradigm, n is in the order of thousands while d is in the order of tens. With
HDMD, the conditions are usually reversed where d n. Correlated variables means unknown
dimensionality of actual information.
The “Course of Dimensionality” The notion of "Curse of Dimensionality" (COD) was coined
by Richard Bellman (1961). It refers to the exponential increase in resources in computing a task
of interest when extra dimensions are added to an associated mathematical space. For example,
it arises in solving dynamic programming and optimal control problems when the dimension
of the state vector is large. The amount of data needed to sustain a given spatial density
increases exponentially with the dimensionality of the input space, i.e., the sparsity increases
exponentially given a constant amount of data, with points tending to become equidistant from
one another (Figure 2.1). In high dimensional spaces, data become extremely sparse and are far
apart from each other. The curse of dimensionality affects any estimation problem with high
dimensionality and it is a serious problem in many real-world applications like Microarray data
(3,000-30,000 genes).
2.1.2 Dimensionality reduction
Taking high dimensional interrelated data, the goal is to reduce dimensionality (d) of a data set
(sample) by finding a new set of variables (k) smaller than the original set of variables (k < d),
that nonetheless retains most of the sample’s information; we can:
• Reduce the dimensionality of problems
• Transform interdependent coordinates into significant and independent ones
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2.1.3 Principal component analysis (PCA)
This method is a classical application of the Single Value Decomposition (SVD). The goal is
the compression of redundant matrices and the identification of important properties inside a
measurements matrix A (m×n). If we use the covariance matrix (assuming that the matrix A
has mean value equal to 0)
COV (A) = 1
n− 1(a1a
T
1 + ...+ anaTn ) =
1
n− 1AA
T
the off-diagonal elements show correlations between samples.
The AAT matrix is the correlation between rows (usually samples in microarray experi-
ments) and the ATA matrix is the correlation matrix between columns (usually genes). As it is
known from linear algebra the SVD returns the fundamental factorization A = UΣV T where U
and V T are two orthogonal matrices and Σ is a diagonal matrix that contains singular values.
Is easy to find that AAT = UΛUT and ATA = V ΛV T , where Λ = ΣΣT . So U and V are two
orthogonal basis for AAT and ATA. The rank of A gives the number of the r first independent
eigenvectors in U and the first r eigenvalues of U are the best basis in the sample space Rm.
Usually the matrix AAT (ATA) has full rank but comparing the singular values σ1, σ2, ..., σn
we could determine how many combinations of samples are revealed by the analysis. Usually,
the rank r is empirically selected as the index of the score in Σ that had a value below a
threshold (threshold= 1; Keiser Criterion). For example if σ4 < thr then rank(A) = r = 3.
2.1.4 Factor analysis (FA)
Factor analysis was initially developed by Charles Spearman in 1904 and the term was first
introduced by Thurstone in 1931. Because FA and PCA share some operational procedures,
they are often confused in the literature. PCA describes the patterns of observed variation
in a sample whereas FA relates the covariance patterns to shared co-variability related to an
underlying latent structure.
2.1.4.1 Correlation matrix The main difference between FA and PCA is that conversely
to PCA, FA has not an unique solution. This is due to the use of a slightly different version
of the correlation matrix used in PCA and FA. In PCA the diagonal of the matrix (aii) is
filled with ’1s’, (this feature of the classical correlation matrix drives to an unique solution)
whereas in FA, the diagonal of the correlation matrix has the ’1s’ replaced with estimates of
communality that measure the variation of a variable in common with all the others together.
This estimating process makes the solution of FA not unique (and different from PCA). Most
of the algorithms employed for the communality measure are based on the squared multiple
correlation coefficient (SMCC) of the variable in the diagonal with all the others.
2.1.4.2 Factors rotation The principal axis theorem on which FA and PCA are based returns
an orthogonal factor matrix. With this factor matrix we have reduced the dimensionality of
the problem but the factors may be not easy to interpret. As showed in table 2.1 two factor
matrices are returned (usually) with FA, one unrotated and one rotated. The unrotated matrix
comes directly from the principal axis theorem (or spectral theorem) that states that every
symmetric matrix A has the factorization A = QΛQT where Λ are real eigenvalues and Q are
orthonormal eigenvectors. The unrotated output makes FA and PCA similar (and confusing)
because results are obtained using analogous mathematical tools (principal axis theorem).
Rotation facilitates the interpretation of factors and makes FA output more understandable.
Rotations are grouped in two classes: orthogonal and oblique (see Figure 2.2) .
Orthogonal Orthogonal rotation assumes that the factors are independent and the rotation
process maintains the reference axes of the factors at 90 degrees.
16 2. Methods
Unrotated factors
variables 1 2 3
variable 1 0.96 -0.03 -0.4
variable 2 0.93 0.12 -0.05
variable 3 0.39 0.84 0.26
variable 4 0.95 -0.21 -0.07
% common variance 51.9 38.1 10
Rotated factors
1 2 3
0.65 0.62 -0.01
0.32 0.12 0.71
0.39 0.77 -0.16
0.75 -0.34 0.48
40.6 35.3 24.1
Table 2.1. Rotated and unrotated factor matrix. Columns define factors, rows variables. The number of factors
is the number of independent patterns of relationship in the data. The first factor in the unrotated factor matrix
contains the largest pattern of relationships (italics). The second one delineates the next largest pattern and so
on. The total amount of common variance described by each pattern decreases successively. In the unrotated
matrix factors are unrelated with each other. In the rotated matrix the patterns of relationship are distributed
over all the factors. Factor 1 and 2 are related with variable 1.
Fig. 2.2. Two factors structure rotation; red lines indicate the new position of the rotated factors F1* and F2*.
Left: orthogonal structure rotation. Curve arrows show direction and degree of rotation, straight arrows show
variables. Right: oblique rotation of factors that fit two clusters of variables (straight arrows).
2.2 Next generation sequencing 17
Oblique Oblique rotation does not require the reference axes to be at 90 degrees. This rotation
may be more realistic representing the clustering of the variables more accurately.
The rationale is that rotations simplifies the factor structure and makes interpretation easier.
Thurstone [THU46, THU47] suggested five criteria to identify a simple structure. A matrix of
loadings (where rows correspond to the original variables and columns to the factors; see table
2.1) is simple if:
1. Each row contains at least one zero (or a small value).
2. For each column, there are at least as many zeros as columns.
3. For any pair of factors, there are some variables with zero loadings on one factor and
large loadings on the other factor.
4. For any pair of factors, there is a sizable proportion of zero loadings.
5. For any pair of factors, there is only a small number of large loadings.
All the various rotation methods have, as a guiding principle, the simple structure concepts
and the results, after rotation, should have become simple in their appearance
2.2 Next generation sequencing
The first two complete genome sequences of living systems became available in 1995 and were
the genomes of two bacteria: Mycoplasma genitalium [FGW+95] and Haemophilus influenzae
[FAW+95]). Since that year more than 800 genomes were sequenced providing a huge amount
of material for comparative analysis.
As stated by von Hejne [Hei87]
...molecular biology is all about sequences. First, it tries to reduce complex bio-
chemical phenomena to interactions between defined sequences...
the assumption of bioinformatics is to consider different biological problems as problems defined
on sequences (or strings). In the genomic era, after more than 40 years since the first global
alignment algorithm was published [NW70] and in which new sequencing technologies are able
to produce Giga bases per day the central challenge in computational biology is still sequence
alignment.
2.2.1 Sequence comparison
The interest in developing computer algorithms to analyze DNA sequences produced with new
sequencing technologies increased in the 1970s.
In 1970 a method based on matrices was described to compare two DNA sequences [GM70].
At the same time Needelman and Wunsch [NW70] started a detailed examination on the
sequence alignment using dynamic programming. This idea was the seed for a plethora of
methods that where developed in the in subsequent years.
2.2.1.1 Distance between two sequences There are several ways to assign a distance
between sequences. The simplest one is to use an edit distance. It is a distance in which each
edit operation on single characters that transforms one string to the other string is defined with
a score. The edit operations are:
• Match (M); corresponds to identity or to non operation.
• Substitution (S); is a replace operation.
• Insertion (I); is the insertion of a character in the first string.
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• Deletion (D); is the deletion of a character in the first string.
An insertion in the first sequence is a deletion in the second and the opposite. For example
if s1 = ACTTACTCAG and s2 = actgtgctat the sequence s1 can be edited to become s2 as
follows
ACT TACTCAG
MMMIMSMMDMS
actgtgct at
So we can define the edit distance between two sequences s1, s2 as the minimum number of
edit operations needed to transform s1 in s2.
2.2.1.2 Dynamic programming approach The edit distance problem could be solved via
dynamic programming. The main idea is that if we have two sequences s1, s2 the minimum
number of edit operation needed to transform the first i letters of s1 and the first j letters of
s2 is called D(i, j). So if the two sequences have length m and n respectively the edit distance
between s1 and s2 is exactly D(m,n).
The dynamic programming approach computes D(m,n) computing all the D(i, j) for each
the combinations of i and j starting from 0 to m and n.
2.2.2 Local and global alignments
When we compare two sequences the two strings may be or not similar in their entirety. Global
alignments expect that the whole sequences are similar and compute the edit distance on
the complete length of the sequences. On the contray local alignments find and compute edit
distance on regions that exhibit similarity.
2.2.3 The Giga base era
All new sequencing technologies in production, including 454, Illumina, SOLiD and Helicos, are
able to produce data in the order of giga base-pairs (Gbp) per machine/day. Researchers have
quickly realized that even the best tools for aligning capillary reads are not efficient enough
given the unprecedented amount of data and many new alignment tools have been developed
in the last few years. Most of the fast alignment algorithms construct auxiliary data structures,
called indexes, for the read sequences or the reference sequence, or sometimes both. Depending
on the property of the index, alignment algorithms can be largely grouped into two categories:
algorithms based on hash tables, algorithms based on suffix trees.
2.2.3.1 Algorithms based on hash tables BLAST was the first aligner that used the idea
to construct hash tables to speed up the alignment. All hash table based algorithms essentially
follow a seed-and-extend paradigm. They keep the position of each k-mer sub-sequence of the
query in a hash table with the k-mer sequence being the key, and scan the database sequences
for k-mer exact matches, called seeds, by looking up the hash table. For example, given the
reference sequence ACTCACTGACTT and the query actg, an algorithm with k = 3 builds on the
query a hash table with two components act=000111 and ctg=011110. In table 2.2 it is showed
how the scan works.
Then for each match the algorithm extends and joins the seeds first without gaps and then
refines them by a Smith–Waterman alignment.
spaced seed Ma et al. [MTL02] discovered that seeding with non-consecutive matches improves
sensitivity. For example, a template ‘111010010100110111’ requiring 11 matches at the ‘1’
positions is 55% more sensitive than BLAST’s default template ‘11111111111’ for two sequences
of 70% similarity. The template with internal mismatches is called spaced seed. Most of the
2.2 Next generation sequencing 19
k-mer Hash code Match
ACT 000111 *
CTC 011101
TCA 110100
CAC 010001
ACT 000111 *
CTG 011110 *
TGA 111000
GAC 100001
ACT 000111 *
CTT 011111
Table 2.2. Hash table for the reference sequence ACTCACTGACTT. In this example 4 matches are found (*). The
two central matches combined together give a perfect match for the query on the reference. The hash code is
an integer composed by six bits, two bits for each base using this schema: A=00; C=01;G=10;T=11.
Program Data Structure SOLiD
Bfast HASH Yes
BLAT HASH No
Maq HASH Yes
megaBLAST HASH No
Mosaik HASH Yes
Bowtie Suffix Yes
BWA Suffix Yes
Table 2.3. Short reads aligners.
tools that use spaced seeds allow k-mismatches. For instance, Maq [LRD08], builds six hash
tables to index the reads and scans the reference sequence against the hash tables to find the
hits. It ensures that the first 28-bp of the reads with two mismatches or fewer will be hit.
With this kind of methods it is possible to align a query on a L-long target sequence in
O(kL) time, where k is the number of mismatches, independently of the length of the query.
2.2.3.2 Algorithms based on suffix trees A suffix tree is a data structure that permits to
solve problems related to pattern matching in linear time. The classical application is to find
the sub-string s in a text T in a time that is O(length(s)) regardless of the length of T .
A simple suffix tree is shown in Figure 2.3 where a naive procedure is used only to give an
intuition of the data structure. Methods that implement suffix trees and their modifications
could search the N -long query in O(N) after that the suffix tree, for the L-long target, is
built in O(L). However a classical suffix tree takes O(L2) space making the tree construction
impractical. Improvements on data structure compression achieve linear spaces and linear time
search.
The popular aligners for short reads are presented in Table 2.3
2.2.4 SOLiD reads
As it was described in 1.3.1.3 the SOLiD technology reports two adjacent bases at the same
time and a single color sequencing error makes the following sequence wrong. For this reason
algorithms that naively decode a color read will fail. The optimal approach is to revert the
target sequence in color-code, align reads and target in the color space and then convert the
result of the alignment into base code. Most of the tools use this strategy to align SOLiD reads
to target (see Table 2.3).
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Fig. 2.3. Suffix tree for string s =”TREREREC”. First the method enters a single edge (node 1) for the complete
suffix S(1,m) where m is the length of s; then enters suffix S(i,m) into the tree for i that goes from 1 to
m. Edges are labeled with the string that is found in the longest path from the root (R) whose previous label
matches a prefix of S(i+1,m). When no further matches are possible and the suffix S(i+1,m)is not finished, the
algorithm breaks the previous edge and inserts a new node (nodes u, v, w and y) just before the first character
on the edge that mismatched.
Part II
Projects
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Chapter 3
In silico SNP detection, probes design and Illumina’s
Porcine Chip annotation
3.1 Description
The lack of a pig genome assembly, the need of a procedure to map an obesity-related human
set of genes (ORH) on the porcine coding-space and the request to expand the ORH into a
new ORH-related set (OR2H) hampered the pipelines already developed for SNPs discovering.
Any tool used in SNPs discovery contains at least two main components: 1) one methods to
align short sequences of different individuals to a reference genome using alignment algorithms
[MM88] and 2) a system that scan the alignments in order to find SNP candidates (PolyPhred
[NTT97], Maq [http://maq.sourceforge.net/index.shtml] and others). Many complex
pipeline was developed to detect SNPs in pigs, using EST [PSH+07, TVV+06, TLV+08] or
using a genome-wide approach [KKK+09]. All these systems are unusable for our aims since
they can not exploit, in the same time, information that arise from sequences that come from
two different species. Moreover their complexity complicates the re-parameterization of the
tools making existing pipelines useless for our specific goals.
To overcome the constrains imposed using “general purpose” pipelines we addressed the
request formulated in the project:
1. designing a comparative and systemic approach that uses the human interactome to select
and recruit genes that are linked with genes in ORH;
2. extracting and implementing a medium density chip in which a set of genes potentially
involved in fat traits regulation are included;
3. assigning a possible significance to most of the SNPs included in the new Illumina’s
PorcineSNP60 BeadChip array that will be used to address the study from a genome
wide point of view.
The first two steps were performed at the beginning of the PhD when the complete assembly
of the pig genome was not disposable while, after the release of the pig genome in 2010, the
third task was executed.
3.2 Platform implementation
The detection of the SNPs was obtained analyzing public sequences achieved using capil-
lary DNA sequencing machines, such as the ABI PRISM 3100. These machines generate vast
amounts of raw sequence data with little user intervention. So we developed a framework to
facilitate automated DNA sequence analysis connecting most of the standard software used to
analyze such kind of data. The implementation is based on a standard 3 independent layers
architecture: 1) a data layer; 2) a logical layer and 3) a presentation layer (Figure 3.1).
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Fig. 3.1. The platform for SNP detection in animal models.
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3.2.1 Data layer
The data layer contains the datasets used for SNP detection/annotation and gene expansion
and is responsible to store, maintain and provide information efficiently. Data-sets are saved
for convenience in a mySQL database server. The schema of the tables was kept identical to
the schema provided by the maintainers of the database from which tables are from. Custom
tables are designed in order to achieve a normal form.
Data-sets Expressed sequences (2,224,772) and EST trace records (1,035,200), consisting in
over 2 billion of bases, were retrieved from ncbi using query_tracedb (http://www.ncbi.
nlm.nih.gov/Traces/). The trace sequences derive from two cDNA libraries, the Sino-Danish
Joint Venture Partnership (http://www.piggenome.dk/)and the US Meat Animal Research
Center (http://www.ars.usda.gov/). All the sequences were retrieved in fasta format. Hu-
man genes (more than 5,000 cDNA sequences) were obtained from ENSEMBL (http://www.
ensembl.org/) via Biomart (http://www.ensembl.org/biomart/martview) using symbols
curated by the HUGO Gene Nomenclature Committee at the European Bioinformatics Insti-
tute (HGNC) (http://www.genenames.org) to query the database. 57,444 pig partial genome
fragments are downloaded from NCBI whereas assembled chromosomes was obtained from
ftp.ncbi.nih.gov/genomes/Sus_scrofa. The STRING proteins network (version 8.5) was
downloaded from EMLB after license request (http://string.embl.de). susScrofa genome
version 9 (April 2010) and the new version 10 (September 2010) were the downloaded from
http://hgdownload.cse.ucsc.edu/downloads.html.
3.2.2 Logical layer
It is responsible in the data processing and contains the programs and the scripts that process
information provided by the data layer. It consists of three main components: 1) a set of scripts
for gene expansion; 2) a pipeline for SNP detection and 3) a subsystem for SNP filtering and
processing. The three components are embedded in a pipeline that coordinates the processes
and the information flow.
3.2.2.1 Expander A local version of the STRING proteins network was moved into our
mySQL database. HGNC gene name convention is used to query the database. The fasta format
of each interacting protein is fetched from a local selection of the ENSEMBL 53 database.
STRING uses eighth different scoring systems that come from:
• literature (Textmining score);
• experimental data (Neighborhood,Gene Fusion, Cooccurence, Coexpression and Experi-
ments score);
• biochemical networks (Databases);
• a resume of the other seven scores (general score).
The general score goes from 0 (no correlation) to 1 (certain correlation). Two genes were
considered as associated when the general association score between them is above 0.81.
1The selection of this threshold was obtained after the following simple procedure:
1. a random sample of 30 genes was selected;
2. the random set was expanded using different thresholds (from t0 = 1.0 to t9 = 0.2, step 0.1);
3. the number of the returned “interactors” was plotted;
4. starting from the more stringent search t0 = 1.0, the threshold was selected manually searching approx-
imately the point pt where the number of returned genes gtn differ a lot from the number gtn−1 .
5. The threshold tn−1 was kept.
The resulting threshold is really stringent compared with the default confidence threshold (0.4) used by the
STRING web service.
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Fig. 3.2. Gene-subnet around LEP (leptin) in STRING. Proteins are represented by nodes and scores by edges.
Marked edges represent relations where scores are above a threshold. In this picture all the proteins are directly
connected with LEP with at least one score; GHRL, LEPR and ENSP00000319435 are linked with LEP with
two or more scores. In our system I used only the general score that resume the other 7 scores.
Briefly, a query procedure implemented in python takes a list of genes and return a set of
genes that shares a general association score above 0.8 (Figure 3.2). In our case the input gene
list is the ORH set. In this set each gene is labeled using the HGNC nomenclature whereas
in STRING each node in the interaction map is labeled with a unique ID that represent the
ensembl Proteins id. To allow the use of the standard human gene nomenclature a dictionary
provide a reversible conversion between HGNC name and ensembl Proteins id.
ORH contain a non-random genes sample that belong to the obesity pathways. After the
expansion procedure connections between genes in the ORH are highlighted and a new set, the
OR2H, has been obtained. As shown in Table (3.1) more than a half of the genes in the ORH
are covered by the OR2H. As a matter of fact, 163 genes (71.5%) in the ORH set were retrieved
via expansion procedure. The probability that an expansion procedure, with a random set of
genes, retrive the same fraction of original genes approach to zero.
3.2.2.2 Contigs reconstruction The pipeline was implemented on a Linux system based on
a 2x4 cores architecture. It was developed using a mix of shell scripts and Perl modules. The
scripts have been used to connect and coordinate several packages freely available for academic
use.
We divided the identification of raw SNPs in the obesity related gene sets (ORH and OR2H)
in a 2-step process:
1. BLASTN [AMS+97] has been used to align the human genes to the EST dataset and
obtaining, for each human gene, a cluster of orthologues porcine ESTs.
2. repeatmasker [SHG] was used to remove portions of low complexity DNA from the
clusters and Phrap/CrossMatch [GAG98] have been used to assembly EST clusters
(http://www.phrap.org). Alignments and contigs are returned in .ACE format (Figure
3.3) where each sequences cluster (putative porcine gene) is saved in single file. ACE files
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QA 1 356 1 356 DS rmed08c_p23.y1
RT{ gi|18283.. matchElsewhereHighQual phrap 36 356 090304:170210 }
RT{ gi|18281.. matchElsewhereHighQual phrap 1 292 090304:170210 }
CO Contig14 1102 31 193 U
aaATCCCAAGGGCAAGAGCTGCACACTTACTGCCTGTGCTCCTTCCCAGC
TGGGGCTGAGGGCCACG*GGAGGGGCAACTCTGGAAATAAAGTGGAAGGA
GGGCTGGGCTGAGCCGGGAAGTGTTGAAAATCTGGGAGGCTGAGAGTGGA
...
ATCCCacaccccctgaccCCCacaggACCATGAATGaggaagcaagggga
acggctggaaatctgggctgggttggacaaaggacaactgagggttcttg
BQ 0 0 50 50 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60
60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60
60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60
60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 .. ..
...
Fig. 3.3. Contigs in ACE format. This text format is space consuming and is not easy to manage. A parser has
been created to extract and provide SNPs information to the next steps.
GE ABCG5_44.screen.rel
NA Contig1 1 1
NA Contig2 2 2
NA Contig3 4 4
//
GE ABCG5_513.screen.rel
NA Contig1 1 1
NA Contig2 2 2
NA Contig3 4 4
//
GE ACE_111.screen.rel
NA Contig1 1 1
NA Contig2 1 1
...
NA Contig9 7 7
NA Contig10 8 8
SQ gCCACATTCCTTCAAGTGTGCCTTACATCAGGTACTTTGTCAGCTTCATCATCCAGTTCC...
PR ATFLQVCLTSGTLSASSSSSSSMRRCARRXGHKXPPAQV*QLPVQGSREAPGGRHEAGPQ...
OR gnl|ti|1377353023 gi|182503309|gb|EW285412.2|EW285412 gi|153...
SN 123 GGGTTTT
PS __________________________________________________V
FR CGCTGTGCCAGGCGGCG*GGCCACAAA*GGCCCCCTGCACAAGTGTGACAGCTACCAGTC...
NA Contig11 37 37
//
Fig. 3.4. Flat text format returned by the .ACE parser. Each row start with a field with two letters. GE stands
for GENE and flag the beginning of a new record for the gene; // is the end of the record. NA, indicate a new
contig. If a contig contains one or more variations the NA field is followed by: SQ, the contig sequence; PR
(optional), the sequence of the translated protein; OR, the ID list of the EST that originate the contig; SN,
the column vector in the alignment that contains the variation; PS, the position of the SNP on the fragment
FR (101 bp length) that contains in the middle the variation. In this example 3 genes are listed. The first 2
isoforms of ABCG5 contain no variations. In the gene ACE a variation is found in Contig10 (composed by 8
EST). From the SN field we see that in position 123 (Contig10 coordinate) the variation contains 3 G and 4 T.
are parsed by a home made script that extract raw SNPs from the contigs and return
flat files (Figure 3.4) that contain information in a format easily manageable by humans
or parsers.
3.2.2.3 Filtering and processing module Our procedure is affected by artifacts deriving
from a well defined source of noise. This noise is introduced by the clustering procedure owing
to the inter-species paralogs/pseudogenes. Such artifacts are composed by contigs containing
regions with high density of SNPs. We implemented a fast strategy assuming that the fre-
quency of SNPs in coding regions is one mutation every 300 bases [RGA03] and that the SNP
distribution on DNA may be characterized, at first approximation, by a Poisson process [KN01].
For each pair of SNPs we compute the probability p(n − (n + l)) < 2 according to the
relation
p(n− (n+ l) = k) = e
−λl(λl)k
k!
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where n− (l+1) is the number of SNP in a sequence of length l, λ is the mutation intensity
parameter (1 mutation each 300 bases) and k(= 2) is the number of observed events. So the
probability that we observe two or more mutations , under the hypothesis of a poissonian
process in a DNA stretch of length l, is
p(n− (n+ l) ≥ 2) = 1− (e−λl(1 + λl))
If the returned probability p is under 0.05 we reject the hypothesis that two consecutive
SNPs follow the selected piossonian model and the two mutations are labeled as “bad” (as
“good” on converse).
For each SNP labeled as “good” we attempt to annotate the following information: a) the
putative gene name, b) the contigs number and the positions in which the SNP is found, c)
the variation introduced, d) the minimum allele frequencies (MAF), e) the minimum allele
count (MAC), f) the deep of the alignment, g) the sequences sources id, h) a genomic sequence
centered on the SNP for genotyping and i) the sources of the pig genome fragments used to
extract genomic sequences.
Furthermore, on each polymorphic location a score was evaluated to weight the “impor-
tance” of a SNP on the basis of the number of EST that contain the mutated base (MAC
number). We calculated the probability PSNP , under a simple binomial model, that at a spe-
cific location the transition from base X to base Y (X → Y ) occur in at least k sequences in
an alignment of n EST, where k is the minimum allele count (MAC) of the polymorphic site.
Under these assumption the probability that a SNP appear by chance is
PSNP = 1−
k−1∑
i=0
(n
k
)
P iX→Y (1− PX→Y )n−i
where PX→Y = 0.0033 is the probability that a base X is mutated. This score has been used
to sort variations on the basis of the number of animals that bring the variant and to help the
choice of the SNPs that will be used to design the custom chip.
3.2.2.4 Probes and chip design The top of the iceberg under my responsibility was the
release of portions of genes that contain SNPs helpful to design the GoldenGate Illumina chip.
A mix of methodological and technological constrains could reduced the number of the SNPs
potentially useful in the chip design:
• Use of human genes to extract porcine EST. The base of our argumentation is that
humans and pigs are species close enough to assign a porcine homologous to each human
gene.
• Paralogs noise. Due to the previous point the number of paralog ESTs processed in the
pipeline is higher than the number of paralog EST expected using genes that arise from
the same organism.
• Low coverage. The mean coverage is about 3.3 106·5001.5 108 = 11 , where 3.3 106 is the number
of ESTs, 500 is the mean length of each EST and 1.5 108 is the number of bases that
belong to the trascriptionaly active part of the pig genome.
• Lack of an assembled genome. Only recently two versions of the pig genome were released.
No information about intergenic/UTR/introns/pseudogenes regions was provided to the
researcher before 2010.
• Length constrains to design Illumina probes (200 bases). Genomic DNA samples obtained
from Italian Large White pigs has been used for genotyping experiments thus information
about introns must be provided for probes design. This request was the strongest limi-
tation because the contigs extracted were build on ESTs that contain only transcribed
DNA.
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Fig. 3.5. Galaxy instance that compare the alignment obtained using two different versions of the pig genome
of the probes present in the 60K SNP chip.
We exceeded, partially, the limitations in the last point obtaining information on pigs ex-
ons/introns gene structure querying chromosomes and BAC clones with our contigs via
BLASTN. A portion of 400 bases is returned for each alignment longer than 20 bases2 and
with identity score above 96%. Because the portion that contains the SNPs could be located
nearest an exon/intron splice-site a 20 bp long selection is required to avoid a lack in sensitivity.
3.2.3 Presentation layer
The results provided by the logical layer was displayed on a local instance of Galaxy [GNT10].
This platform is based on a complex server architecture where different mechanisms are em-
ployed to compose a rich application server in which users are free to analyze/query/share/modify
biological data (see figure 3.5). We developed several wrappers in order to control via Galaxy
a wide spectra of tools.
3.2.4 String expansion
In our test case the starting candidate gene set (ORH) include 249 human genes (selected
from literature and from the Gene Obesity Map, http://obesitygene.pbrc.edu) that has
been expanded to include some other sequences from the human interactome (OR2H; Table
3.1). From 249 genes 229 (91.6%) are found have a corresponding protein in String. Using the
proposed threshold we expanded the obesity gene set to 2,431 genes where 229 are still known
and 2117 are completely new. Figure 3.6 shows the view (presentation layer) of the implemented
tool to control the expansion procedure. The tool is embedded in a local instance of the Galaxy
Framework.
3.2.5 SNPs search
Results are kept separate for genes in the ORH and OR2H sets (see Table 3.2). For both
sets searching procedure has been performed in contigs derived from 3,259,972 pig EST. The
distributions on the number of ESTs in contigs for both the dataset are shown in Figure 3.7.
2Roughly speaking I adopted this threshold (20 bases) because it gives, under an uniform model, 1 false
positive alignment each 4
20
500·106 =
240
500·106 ≈ 1000·10
9
500·106 = 2 · 103 alignments, where 500 · 106 is the number of
bases that compose the queried database.
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Fig. 3.6. The page is divided in three parts. The middle one is where the user can choose databases, genes list
and parameters for the expansion procedure.
Input Data Number
ORHa
Total 249
Uniqueb 86
OR2Hc
Total 2,431
Unique 2,202
Common 163
Table 3.1. Expanded Gene Set statistics. aFrom literature and database search; bfor 20 genes in the ORH set
we did not found correspondence in STRING; cusing a threshold > 0.8 for the global score.
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Input Data Output Data Number
Pig EST sequencesa 3,259,972
ORH 249
Contigs f 3,191
Raw SNPsb 7,221
Filtered SNPsc 1,583
Annotated SNPsd 733
OR2He 2,202
Contigs 29,018
Raw SNPs 60,251
Filtered SNPs 12,159
Annotated SNPs 6,393
Genes with probes 690
Table 3.2. SNP statistics of the test case. afrom NCBI; bafter the pipeline stages; cusing the filtering procedure
based on the Poisson process with λ = 0.0033; dat least a genomic fragment of 400 bases is associated with the
SNP; eafter a search in the human interactome of String; f the number refers to contigs composed by al least 4
EST.
Fig. 3.7. The distribution of the number of ESTs per contig in A) the ORH and in B) OR2H genes.
The first stage of the pipeline identified 7,221 bi-allelic raw SNPs from 3,191 contigs found in
the ORH set . The contig assembly process on the OR2H set gives 60,251 raw SNPs that, after
the filtering procedure have been reduced to 12,159 (20.2%) mutation. The polymorphism rate
obtained is ≈ 1 mutation each 800 base pairs and every gene sequence contains on average 3.6
SNPs. This result approximate the right bound (1/1000) in the expected SNP density interval
of a mammalian genome. The small mutation rate could be explained with some considerations.
First, we search SNPs in coding regions were the selective pressure is high and the mutation
rate is lower than in non coding region [ZFHEB03] and second, the low coverage of the EST on
the porcine genes (≈ 11× and 0.32 for coverage and MAF, on average),reduce the sensitivity
of the method that return variations that appear in a small population’s fraction. As shown in
Figure 3.7, 95% of the polymorphisms have less than 9 ESTs that bring the alternative allele
(MAC) and about the 56% of them (removing singletons) have MAC that is ≤ 2 . This value
is useful to estimate the signal to noise ratio: higher is the number of EST aligned with the
alternative mutation and lower is the probability that the mutation is due to random errors in
the EST sequencing procedure. This observation driven the decision to use the binomial model
showed in section 3.2.2.3 to score each filtered SNP with the probability that the variation is
accidental.
Here we want to start a short discussion on the issue of the SNPs isotypic multiplicity.
We are using a set of 2,431 human genes mapped on a space of 5,290 sequences; this implies
that each gene is represented, on average, by ≈ 2.2 isotypic sequences. Identical SNPs found
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GENE PP HS Common Experimental
ADRB2 b0 c(0) 0 (0) 0 1
AMPD1 2 (1) 0 (0) 0 1
BDNFa 1 (1) 0 (0) 1 1
CIDECa 1 (1) 1 (1) 0 1
CSTB 0 (0) 1 (1) 0 1
CTSL1 14 (1) 13 (1) 1 1
CTSSa 6 (1) 0 (0) 0 1
FTO 2 (0) 0 (0) 0 1
LEF1 3 (1) 4 (0) 0 2
PON3 2 (1) 1 (0) 1 4
Total 31 (7) 20 (3) 3 (2) 14
Table 3.3. Experimental comparison. aExperimental unpublished data; the experimental validation is done by
resequencing. bnumber of SNPs found; cnumber of experimental SNPs found.
in different isoforms from the same gene are kept separated for two reasons, biological and
technical:
1) the meaning of the same mutation in different isoforms expressed within a distinct spatial
or temporal pattern could lead to different biological effect;
2) the design of probes or primers for sequencing purpose must take into account the genomic
neighborhood (introns, untranslated regions, promoters) that distinguish one isoform to one
other.
All the 12,159+1,583 filtered SNPs were aligned on the genomic sequences and for 6,393+733
of them the procedure returned a probe that fit the technical specifications required to design
the Golden Gate. After the whole process 690 new genes, potentially related to obesity, were
disposable to further investigation.
3.2.6 In silico comparison
To test the performance of the SNP search procedure we compared our results with HaploS-
NPer (with default parameters), a web tools that was, at the time in which we developed the
tool, the only released pipeline for SNP detection able to perform SNPs detection in a set of
template sequences.
We used a random sample from OHR, composed by 138 genes3. 67 out of 138 (48.8%) genes
appear to contain SNPs for at least one pipeline (our or HaploSNPer). We detected 255
SNPs in 52 genes and HaploSNPer 1,338 SNPs out of 56 genes. No overlapping between genes.
On average our pipeline and HaploSNPer detect 3.81 and 19.97 SNPs per gene. 1,338 SNPs in
56 genes highlights problems in the SNPs selection procedure.
A deeper data analysis shows that this high mutation rate discovery is due to problems
with paralogs and orthologs sequences discrimination. We found that for at least then genes
HaploSNPer detects more than 10 SNPs in a short stretch of DNA (few tens of bases). For two
of these genes, IGF2 and ACP1, HaploSNPer detect more than 100 SNPs on a single sequence.
This problem appears when sequences deriving from different organisms are aligned (and this is
the case) [RSS01]. A second source of error that affect the procedure adopted by HaploSNPer
is the use of the templates as a source of variation (to improve the sensibility of the method).
In an inter-species alignment, the template sequence must be removed from the alignment in
order to avoid false variation discovery (hybrid-SNPs). In 5 genes in which Haplo detects SNPs
(KLF5, GHRHR, IKBKB, INPPL1 and LACTB) the variation originate if the polymorphism
appear in the seed sequence. When genes with paralogs or with hybrid-SNPs were removed,
the performance in term of average SNPs per genes appear to be similar (2.98 and 2.21 SNPs
3We have reduced the dimension of the test set to 138 genes because the analysis of the results was performed
by hand
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Gene symbol P SNP type SNP location Chromosome Source
TBC1D1 0.000137 G>A Intron 2 8 resequencing
CALR 0.000601 A>G Exon 1 2 in silico
PPARG 0.000690 A>G 5’UTR 13 literature
JAK3 0.000736 T>C Exon 23 2 in silico
NT5E 0.000937 T>C Exon 7 1 in silico
RRAGD 0.002064 T>C Intron 3 1 literature
MC4R 0.002220 A>G Exon 1 1 literature
VCAM1 0.002281 T>C Exon 5 4 in silico
Table 3.4. List of genes associated with BFT with P<0.10.
on average) for our pipeline and HaploSNPer. The Number of total SNPs found are 228 and
only 16 (7%) are common.
Then we compared the performance on a set of 10 experimental validate genes with 14
validate SNPs. As is shown in table our pipeline detect 31 SNP and HaploSNPer detect 20
SNP wheres only 3 SNPs are shared. More interesting are results on the experimental validated
SNP where our pipeline detect 7 SNP (50%) and HaploSNPer 3 (21.5%) showing a consistent
overperformance of our selection strategy.
3.3 Probes testing
Sequencing of fragments amplified from 60 obesity related genes identified 84 SNPs, 67 of which
were chosen for genotyping. Other 131 SNPs obtained from published literature on markers
associated with fat deposition traits in pigs were included in the genotyping SNP panel. In silico
expressed sequence tags database mining reported 733 + 6, 393 = 7, 126 SNPs. From the 7,126
SNPs found in silico 565 were analyzed whereas 198 were selected from published literature on
markers associated with fat deposition traits in pigs. On the whole adding the different sources
from which we identified SNPs, 763 SNPs were included in the GoldenGate panel that was
used to perform the association study.
This study was conducted on two extreme and divergent groups of two generation unrelated
females of these triplets (evaluated in the period 1996-2007) chosen according to their Estimated
Breeding Values (EBV) for BFT (280 with most negative and 280 with most positive EBV)
within a population of ~12,000 pigs. Average EBVs for the most negative and positive selected
pigs were –9.4 ± 1.6 and +8.0 ± 5.95 mm, respectively. Genomic DNA was extracted from
blood using standard protocols.
For 86 SNPs the designed GoldenGate tests were not successful leaving 677 SNPs: 169 SNPs
were monomorphic in the analyzed pigs; 187 SNPs had a MAF<0.05; and 321 had MAF >0.05.
Allele frequency differences between the two extreme groups of pigs chosen according to
their BFT EBV were evaluated for 321 SNPs with MAF >0.05. Of these SNPs, 65 showed P
nominal value <0.10. Thresholds of 0.10 and 0.20 corresponded to P nominal values of 0.003 and
0.025, and included 8 and 30 SNPs, respectively. For brevity, only genes whose polymorphisms
were significantly associated with BFT at P<0.10 are reported in Table 3.4. . The role of the
other significant genes on BFT remains to be further evaluated.
Most of these genes map in chromosome regions in which QTL for BFT and other related
traits have been localized. The recruitment strategy of candidate genes based on the human
interactome followed by an association study of in silico detected SNPs represents an innovative
approach that may open new possibilities for the identification of genes affecting obesity related
traits in pig enforcing the role of this species as a model for human obesity.
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Chromosome NumberSNPsMappeda Frequency SNPa NumberSNPsMappedb Frequency SNPb
chr1 6055 2.04E-005 6299 2.13E-005
chr10 1622 2.01E-005 1487 2.23E-005
chr11 1726 2.05E-005 1732 2.17E-005
chr12 1403 2.18E-005 1355 2.36E-005
chr13 3836 1.80E-005 3504 2.41E-005
chr14 3600 2.34E-005 3900 2.63E-005
chr15 2631 1.72E-005 2516 1.87E-005
chr16 1702 1.98E-005 1663 2.15E-005
chr17 1548 2.23E-005 1546 2.40E-005
chr18 1200 2.00E-005 1203 2.22E-005
chr2 3138 1.92E-005 3026 2.16E-005
chr3 2566 1.80E-005 2479 2.01E-005
chr4 3374 2.44E-005 3529 2.59E-005
chr5 2153 1.95E-005 2193 2.18E-005
chr6 2961 1.89E-005 2669 2.16E-005
chr7 3126 2.33E-005 3324 2.44E-005
chr8 2571 1.74E-005 2406 2.01E-005
chr9 2946 1.94E-005 2875 2.17E-005
X 1384 1.03E-005 1293 1.03E-005
Y 10 6.24E-006 0 -
Total 49552 48999
Table 3.5. Probes distribution on chromosomes in asusScrofa10 and bsusScrofa9.2.
3.4 Illumina’s PorcineSNP60 BeadChip array annotation
High density single nucleotide polymorphism (SNP) genotyping arrays have been recently de-
veloped in several farm animal species. Their use makes it feasible genome wide studies for
different purposes, including also new applications like genomic selection. However, to fully
exploit the potential of these arrays, SNPs, that are usually anonymous, should be character-
ized and precisely assigned to their chromosomal position. These two issues are particularly
challenging when the genome sequences are still under refinement, as in the case of most farm
animal species. In particular, for the pig several versions of the genome have been preliminarily
released to the public. Recent updates provided new versions of the porcine genome (Sscrofa9
[ABC+10], http://www.ensembl.org/Sus_scrofa/Info/Index August 2010; and Sscrofa10,
Sept. 2010). The Illumina’s PorcineSNP60 BeadChip array [RCA+09] includes 62,163 SNPs,
that were originally positioned on the Sscrofa7 genome pre-assembly version. The last effort
made on this project was to assign these SNPs to the two latest versions of the pig genome as
a first step for their functional annotation.
3.4.1 SNP assignment and annotation
Probes of the chip were aligned to Sscrofa9 and Sscrofa10 using megaBLAST4. Only matches
with identity ≥ to 94% were considered. Probes with unique match on the genome were con-
sidered as mapped. In case of multiple significant matches, the alignment with the highest
score was considered. The position of each SNP was calculated on the basis of the alignment
data knowing that the polymorphic site is the first base that comes after the last base of
the probe. We used this simple formula: SNPp = Genp ± (51 − Probep), where SNPp is
the SNP position, Genp is the position of the last base aligned in the reference genome and
Probep is the position of the last base aligned in the probe. The sign of the operation is con-
4parameters: -e 1e-10, -W 28, -p 90 no filtering for low complexity.
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SNP type Number
Intergenic 31892
Intron 14347
Downstream 2404
Upstream 2377
3Prime 103
5Prime 36
Synonymous 699
Non-Synonymous 291
Stop Gain 5
Start Gain 4
Stop Lost 0
Start Lost 1
Splice site 25
Table 3.6. SNP effect on genes. We used the annotation provided for the susScrofa9.2 assembly.
cordant with the alignment strand (plus or minus). For each SNP position we searched the
reference genome for discordance with the SNP reported in the Illumina definition file. We
detect a discordance if the base in the SNP position was different from the two bases called
in the SNP file. According to these criteria, 48,999 and 49,552 probes were uniquely assigned
to Sscrofa9.2 and Sscrofa10, respectively (Table 3.5 reports distribution of SNPs per chro-
mosome). Transcript records for 20,460 genes were retrieved from Sscrofa9.2 using BioMart
(http://www.ensembl.org/biomart/index.html). The probes defined as mapped were pro-
cessed using snpEff (http://snpeff.sourceforge.net/) to predict their effects (Table3.6).
Most of the annotated SNPs were intergenic (65.63%) whereas only a small fraction were pre-
dicted as non-synonymous (291) and a few others (35) might have a direct functional effect
(Table 3.6). Two files include the list of SNPs uniquely assigned and annotated for the Ss-
crofa9.2 and Scrofa10 genome versions. These files will be provided to the scientific community
after the publication of the results.
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Chapter 4
Searching for Emergent Properties of Cellular Systems
4.1 Observing gene activity
Currently, it is possible to observe the activity (over- and under- expression, presence or absence
of mutations) of almost all molecules of a given type (mRNA, miRNA, DNA) in a single screen
using high-density chips [GN08], or sequencing related techniques [HJ08, WGS09]. Lately, the
number of studies using microarray platforms for analysis of mRNA are quickly being followed
by similar analyses related to miRNAs [VCL+06, YKV+08]. Only recently both types of vari-
ables were analyzed simultaneously [LPP+07, LFG+07, PBK+10], while, typically, both types
of data are analyzed in search for (i) molecules sharing similarity, using simply the expression
available at the time (unsupervised approaches, [But02]) e.g. clustering [Qua01, MO04] and
association networks [MNB+04, MLB08, NRT+07] or (ii) similarity with -or dependency from-
other types of traits, providing for example clinical classes or other non-molecular information
on the samples (supervised approaches, [But02]) i.e. Significant Analysis of Microarray (SAM
[TTC01]), Gene Set Enrichment Analysis (GSEA [MLE+03]).
However, this approach implies to analyze separately different aspects of a system (e.g.,
transcriptional and/or post-transcriptional mechanisms) and the results may not be concor-
dant with analyses of the system as a whole. For example, interactions among miRNAs and
mRNAs may be underestimated or completely overlooked. This lack of information can be
expressed as missing the emergent properties of the system. While the concept of emergent
properties is well known in Systems Theory, it has only recently become an important con-
cept in the area of life sciences, thanks to the relatively new approach of Systems Biology
[Hoc05, ATPP06b, ATPP06a]. Emergent properties arise from hierarchical integration of the
individual components and organizational levels of complex systems, and, biologically, they are
only manifest when the organism is considered in its entirety.
Analogous to emergent properties in systems biology is the concept of latent variables in
multivariate statistics. Latent variables are so-called hidden variables generated in certain types
of multivariate analysis (e.g. factor analysis, see below) which are not evident in original ob-
served data. Rather, these latent variables emerge from consideration of the covariance patterns
when a large number of relevant variables are analyzed simultaneously. These latent variables
may reflect a summarization of causal indicators underlying observed biological variability.
Given the parallelism between biological system’s emergent properties and latent variables,
we sought- quite naturally- to investigate the ability of latent variables to describe emergent
properties, by applying multivariate analysis simultaneously to different parts of a biological
system, and notably to transcriptional and post-transcriptional data.
Previously, successful parallel multi-platform analyses were performed integrating genomic
and transcriptional level, by using CGH arrays or SNPs and cDNA arrays [YWF+06, LTTD+00].
This approach portend to explain variations observed at the transcriptional level, based on in-
formation at the genomic level. These approaches can annotate and map different types of probe
IDs onto genomic coordinates [YCL+06], or add analyses at the translational level [MHH+05].
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Model Tumor Grade Anaplastic Glioblastoma Gliosarcoma
SVM (0.92, 0.045 ) (1, 0.0015 ) (0.83, 0.08 ) (0.83, 0.045 )
NB (0.92, 0.045 ) (1, 0.0015 ) (0.58, 1 ) (0.83, 0.077 )
NN (0.92, 0.045 ) (1, 0.0015 ) (0.83, 0.06 ) (0.83, 0.045 )
kNN (0.92, 0.045 ) (1, 0.0015 ) (0.83, 0.08 ) (0.92, 0.018 )
Table 4.1. Model Selection, Alternative Classification Analysis. Tumors type and grade dual discrimination. In
bold Accuracy; in italic p-value. SVM: Support Vector Machine; NB: Naïve Bayes; NN: Neural Network; kNN:
k-Nearest-Neighbors.
However, to date, simultaneous analysis of miRNA and mRNA from the same tissue have used
only profile correlations [LPP+07].
Herein, we expanded analyses of molecular covariation beyond correlation of expression
profiles by using the multivariate statistical procedure of multiple or common Factor Anal-
ysis (FA, [JW02], see Section 2.1.4). FA was used extensively to cluster microarray data
[She01, Pet02b, LSB+05b]. The use of the a priori knowledge on how each sample maps on
tumor classes to constrain the relation among latent variables under study and the factors
obtained permits further data interpretation. In other words we perform a FA that is driven by
data (hypothesis) pre-established to find latent variables that could be investigated to obtain
biological information [CGP+06b].
To constrain the factor model we used Linear Discriminant Analysis (LDA, [JW02]), a
technique used to classify a set of observations into categories (a dichotomy in our case).
Besides LDA, other classifiers (Support Vector Machine, Naïve Bayes, Neural Network and
k-Nearest-Neighbors) were also tested and performances are listed in Table 4.1. We only briefly
mention here that most of the performances are identical for all the classifiers, and only for the
Glioblastomas discrimination LDA shows slightly more accuracy. These results indicate that
the classification analysis is robust and gives stable results independently from the choice of
the classification algorithm.
Factor analysis proceeds from a matrix of pair-wise correlations to extract a small number
of factors that describe the major patterns of common covariation. More formally, the common
factor model is based on the equation D = LF +E, where D are the observed variables, L are
the common factors, F are the coefficients or scores of the factors and E are the unique factors,
under the assumptions that the unique factors are uncorrelated with each other and that F and
E are independent. Since only common variation is analyzed, these individual factors describe
the latent structure underlying the major patterns of molecular covariation.
The sign and magnitude of the factors coefficients reflect the extent and direction of the
correlation between each variable and individual factor and describe the relative contribution
of each variable to a particular pattern of multivariate changes.
FA derives a set of factor scores that gives the relative location of each item in the reduced
latent variable subspace. The resultant factors, coefficients and scores are interpreted in light of
biological knowledge about the specific data under study. FA can define a biological model about
the underlying nature of molecular covariation (e.g. number of patterns of covarying elements
and their relative importance). These models are evaluated both biologically and statistically
and subsequently used to explain the structure and dynamics of complex biological systems.
There exist several approaches to perform data reduction and classification (see for example
Bayesian classifiers [LIT92, Fri98, PKS+07], Support Vector Machine [FCD+00], K-nearest-
neighbor [TCRR+02]), however, FA has already been used successfully in various applications
related to molecular biology, like the identification of multidimensional patterns of molecular
covariation able to describe protein’s structures [AZFD05].
More classical approaches have been designed for effective clustering in the analysis of cDNA
microarrays and Expressed Sequences Tag (ESTs) [Pet02a], as well as in specific applications to
identify genes and pathways related to biological categories that could be associated to relevant
phenotypes in both yeast and humans [LSB+05a] or to test and validate hypotheses on the
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Model Tumor Grade Anaplastic Glioblastoma Gliosarcoma
1 - - - -
2 F 2 (0.92, 0.045) F 2 (1, 0.015) - -
3 F 2 (0.92, 0.045) F 2 (1, 0.015) F 1+F2 (0.92, 0.015) F 1+F3 (0.92, 0.018)
4 F 2 (0.92, 0.045) F 2 (1, 0.0015) F 1+F2 (0.92, 0.015) F 1 (0.92, 0.018)
5 F 1 (0.92, 0.045) F 1 (1, 0.0015) - F 5 (0.92, 0.018)
Table 4.2. Model selection using discriminant analysis. Tumors type and grade dual discrimination. In bold
Accuracy; in italic p-value
association of gene expression to cisplatin resistance in ovarian cancer cell lines [CGP+06a].
One of the advantages of this approach over hierarchical clustering is the possibility to include
genes in more than one category. More recently, FA was used to filter informative and non-
informative data from microarray for gene expression [KLVS+10]. Variations of classical FA
(Bayesian factor analysis) have been used to identify the latent structure that describes the
relationship between transcription factors and genes, using microarray data [PW07]. Previously,
this approach was used to perform gene network reconstruction in E.Coli taking advantage of
literature information, DNA sequences and expression arrays [SJ06].
This chapter describe an application of FA to the composite analysis of multilevel molecular
data.
4.2 Multilevel latent structure
Because miRNAs and mRNAs are processed together, from now on, Factors will always be
likely to include both mRNAs and miRNAs in their composition. To avoid confusion on the
meaning of the word gene, we use the term coding genes to refer to mRNAs and the generic term
genes to refer both to mRNAs and miRNAs. The interpretation of factors based on associating
them to mRNAs/miRNAs (separately considering positive/negative scores) is a novelty of the
presented approach, and will be discussed in details in the coming sections. In particular, in the
following we will describe how to identify and interpreted the latent factors, both using mRNA
and miRNA (indirect) functionalities. Then, we will describe the biological structure emerging
from this analysis, speculating on its clinical meaning. Finally, we will offer a comparison with
the results of an analysis done in parallel.
4.2.1 Identification of multilevel latent structures
We performed several Factor Analyses obtaining Models characterized by 1 to 5 factors (named
here Model n, n = 1, .., 5). Kaiser criterion [vZ85] has been used to identify the number of fac-
tors that show a large variance (common variance in each factor greater than a given threshold,
t) and therefore carry a large amount of the information hidden in the data. Given t = 1 the
number of information-rich factors appears to be 4. Therefore, FA was performed with a growing
number of such factors, from the one with higher variance, up to 5, to test the appropriateness
of the variance threshold. We then confirmed the validity of a subset of the Models using LDA
to identify which factor (or linear combination of factors) was able to best classify tumor grade
and histopathology, based on the statistical significance of Fisher exact test [SR03]. This test,
suited for contingency tables where one or more expected frequencies are below 5, evaluates
the null hypothesis associated with LDA that there are no statistically significant differences
between the a priori clinically defined groups. The models for which the null hypothesis was re-
jected were retained (see Table 4.2 and Methods for details) . Therefore, we performed 4 LDA,
namely between a class and its complement: i.e. high/low grade, anaplastic/non-anaplastic,
glioblastoma/non-glioblastoma and gliosarcoma/non-gliosarcoma, following the original clas-
sification in [LPP+07]. We did not consider oligodendroglioma relevant, because of a single
sample available.
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Factor Ontology Terms Ontology
F1+ Response to external stimulus GO_BP
Secreted, glycoprotein SP
Plasma Membrane, transucer, extracellular, receptor GO_MF,GO_CC, SP
F2− Signal, glycoprotein SP
Cell Adhesion SP
Extracellular region GO_CC
F3+ Gene Expression GO_BP
Table 4.3. Functional analysis of the factors in Model 3. GO: Gene Ontology; BP: Biological Process; CC:
Cellular Component; MF: Molecular Function; SP: Swiss Prot.
Model 3 appears to be the most suitable, since it is able to discriminate between anaplastic
and non-anaplastic tumors with 100% accuracy (based only on Factor 2) and the other two
types of tumors with ' 92% accuracy. Since anaplastic tumors are low grade tumors, Factor 2
is relevant in the identification of low grade tumors in general with ' 92% accuracy, since the
only oligodendroglioma appears to be elusive. It is worth noting that Model 4 shows the same
performance scores, but with a greater number of factors and Factor 4 does not appear to be
involved in class identification.
4.2.2 Interpretation of multilevel latent structures
4.2.2.1 mRNA functional analysis Working solely on Model 3, the mRNAs in each fac-
tor were processed to detect enriched Gene Ontology (GO, [Con01]) terms or UniProt (SP,
[BAW+05]) keywords. The magnitude and sign of the factor scores (not the factor coefficients
from the eigenvectors) give their relative relationship with the expression of miRNA and mRNA.
Consequently, each row in the 3 factors score matrix (F1, F2 and F3) was split into positive
and negative portions (F1+ and F1−; F2+ and F2−; F3+ and F3−) and analyzed separately.
F1+ is associated with GO terms related to response to stress and external stimuli. Terms
from SP keywords like secreted and glycoprotein were also found in this subset. Thus this factor
appears then to be related with cell functions that process signal from the external environment
to the cell with membrane receptors involved to the signal transduction. F2− is also involved
in the signaling, including categories related to cell adhesion, it appears then to be related to
functions like chemotaxis that are involved in inflammation processes.
Finally, F3+ contains coding genes that are related to the biological process that goes
under the general term gene expression. Gene expression includes all the mechanisms such as
transcription, translation, RNA maturation, proteins transport and ubiquitination by which
information coded in the DNA is converted to a functional product. All results are summarized
in Table 4.3.
4.2.2.2 miRNA Indirect functional analysis Since miRNAs are not included in any ontol-
ogy database, we performed an indirect functional analysis by screening the functional terms
associated with the experimentally validated target coding genes of the miRNAs, extracted
from TarBase [PRS+09]. Once the target coding genes were identified, they were manually
annotated via GO terms or SP keywords, as above (see Table 4.4).
4.2.2.3 mRNA/miRNA complex functional annotation We then checked the functional
classification’s coherence between the indirect and direct functional analysis, within each sig-
nificantly annotated factor (i.e. F2−, F3+, since no miRNA appeared in F1+). Thus, globally
speaking, F1+ annotation is unchanged and related to functions that are responsible for signal
transduction. In F2−, 3 out of 7 target coding genes (CXCL12, TM6SF1 and AGTR1) are an-
notated with terms that can be associated to the categories significantly varied in the mRNA
functional analysis: F2− is then confirmed to be a factor involved in functions related with ad-
hesion and/or chemotaxis. For the miRNAs in F3+, 5 out of 8 target coding genes (ARID4B,
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miRNA Gene Name Gene Description
AOF2 amine oxidase (flavin containing) domain 2
ASXL1 kiaa0978 protein
C19ORF2 chromosome 19 open reading frame 2
CHD7 chromodomain helicase dna binding protein 7
CHD8 chromodomain helicase dna binding protein 8
ETV1 ets variant gene 1
GTF2H3 general transcription factor iih, polypeptide 3, 34kda
HEY1 hairy/enhancer-of-split related with yrpw motif 1
HIC2 hypermethylated in cancer 2
ID4 inhibitor of dna binding 4, dominant negative helix-loop-helix protein
KCNH2 potassium voltage-gated channel, subfamily h (eag-related), member 2
MAZ myc-associated zinc finger protein (purine-binding transcription factor)
hsa-miR-17-5p NONO non-pou domain containing, octamer-binding
hsa-miR-20b OLIG2 oligodendrocyte lineage transcription factor 2
POLR2E polymerase (rna) ii (dna directed) polypeptide e, 25kda
PPP2R1A protein phosphatase 2 (formerly 2a), regulatory subunit a (pr 65), alpha isoform
PRMT5 protein arginine methyltransferase 5
RBBP4 retinoblastoma binding protein 4
RBPJ recombining binding protein suppressor of hairless (drosophila)
RERE arginine-glutamic acid dipeptide (re) repeats
RTF1 rtf1, paf1/rna polymerase ii complex component, homolog (s. cerevisiae)
SOX12 sry (sex determining region y)-box 12
SSRP1 structure specific recognition protein 1
STAT5B signal transducer and activator of transcription 5b
TBL1XR1 transducin (beta)-like 1x-linked receptor 1
TCF12 transcription factor 12 (htf4, helix-loop-helix transcription factors 4)
TCF3 transcription factor 3 (e2a immunoglobulin enhancer binding factors e12/e47)
TCF7L1 transcription factor 7-like 1 (t-cell specific, hmg-box)
YBX1 y box binding protein 1
ZNF195 zinc finger protein 195
ZNF43 zinc finger protein 43 (htf6)
Table 4.4. F3+: miRNA and mRNA annotated with Transcription Regulation term. Number of mRNA found
in Factors after multilevel analysis.
MYLIP, HIPK3, E2F1 and NCOA3) are functionally related with the gene expression term
found in the mRNA functional analysis. Interestingly, most of the terms (4/5) are related with
mechanisms of transcription regulation and only one with protein ubiquitination.
After direct and indirect annotation, 2 miRNAs and 31 human coding genes in F3 were
selected as belonging to the same category (see Table 5). Not surprisingly, most of the coding
genes in this list are not predicted to be targets of the 2 miRNAs that appear in the factor. In
fact, the biological meaning of the result is a set of genetic elements that share covariability in
the expression pattern and we know that, e.g. in animals, most of the control on gene expression
is performed by tuning translation. Therefore, the levels of miRNAs and the mRNAs of direct
targets are not directly correlated. As it is also suggested in [LPP+07] we can imagine that our
list of coding genes contains the possible subset of indirect targets (functionally related with
the regulation of the transcription) of two miRNAs: miR-17-5p, and miR-20b. Globally, F3+ is
confirmed to be associated with gene expression, with transcription regulation being the most
common mechanism of expression.
4.2.3 Emergent properties
Since the transcription regulation term (F3+) appears to give the clearest biological informa-
tion, coherent in mRNAs and miRNA, we focused our efforts on this part of the analysis.
Latent structure chromosomal localization Most of the miRNAs in F3+ belong to two poly-
cistronic miRNA genes where miRNAs are lying in close proximity on the chromosome. (The
named clusters are given in italics throughout the paper to improve readability and avoid confu-
sion with clusters emerging from supervised or functional analyses). These polycistronic miRNA
genes are involved in cell proliferation, apoptosis suppression, tumor angiogenesis [Men08] and
T cell leukemia [LLLR07]. The first polycistronic gene (miR-17-92) is composed by 7 miRNAs
and maps on Chromosome 13 whereas the second one (miR-106-363) maps on Chromosome X
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Fig. 4.1. Organization of miRNA clusters miR-17-92 and miR-106-363. Structure of the two polycistronic
miRNA gene and the relations between miRNAs.
and contains 6 miRNAs, details are shown in Figure 4.1. The two clusters are closely related,
in fact, each miRNA on one cluster has at least one homologous in the other cluster except for
miR-17-3p and miR-363 that do not share homology with the other miRNAs (shown in Figure
4.1).
As further corroborating test, we observed that, when searching the target coding genes of
homologous miRNAs (miR-20a, miR-17-5p and miR-106a) the list of predicted targets (Tar-
getscan, [LBB05]) is identical for all miRNAs. Moreover, we notice that only two homologous
groups of miRNAs in the cluster (miR-18 and miR-92) are not part of F3+. If we look at their
sequence in detail we observe that they are very similar to miR-20a with only two mismatches:
one in the loop (miR-18a and 18b) and one after the supplementary pairing region (miR-18b).
This can represent a partial functional redundancy since all the known key regions in target
recognition are identical. Conversely, miR-92 does not share any significant homology with the
other members of the cluster (except for the seed region with miR-363).
Taking into consideration all the redundancies in the clusters, most of the transcript targets
in F3+ are probably under the regulation effect of the expressed miRNAs. It is worth noting
that a cross-hybridization effect in miRNAs could be considered the mechanism responsible
for these association in clusters. But, as reported by the authors of the dataset [LPP+07],
each primer and probe contained zip-coded sequences specifically assigned to each miRNA to
increase the specificity of each reaction so that even small differences in miRNA were amplified
and detected. So, this artifact can be discarded as explanation for the emerging of clusters of
miRNA.
Statistical relevance Interestingly, in F3+, only 2 miRNAs (hsa-mir-9 and hsa-mir-130b) out
of 7 do not belong to any of these two clusters. Their role was shown respectively to be related to
the molecular pathogenesis of ovarian cancer [LOF+08] as well as to schizophrenia and Human
T-cell leukemia Virus-1 (HTLV-1) transformation [BGA+07, YiYB+08]. Six more miRNAs
(miR-106a, miR-18a and miR-18b, miR-20a, miR19b-1 and miR-19b-2) that belong to these
two clusters could not be part of our analysis, as they were not part of Liu’s original dataset.
Given the high density of miRNAs in these clusters, we used the hypergeometric distribution
to compute the probability associated with the hypothesis that a random sampling would give
the same result in terms of number of cluster members in cluster miR-17-92 (3 members out
of 4 total), in cluster miR-106-363 (2 members out of 3 total) and in both (5 members out
of 7 total). The reference group for computing the probability consists of the total number of
detected miRNAs (93). The resultant probabilities were Bonferroni corrected and were equal
to 3.6× 10−3, 0.045 and 2.3× 10−7 respectively. All three are statistically significant.
4.2.3.1 Speculations on molecular-clinical implications Ultimately, we speculated on
how the two clusters between gliosarcomas and non-gliosarcomas. This choice is due to the
fact that our analysis has shown that the combination of factors that carry the more coherent
functional information (both from miRNAs and mRNAs signals) was the combination able
to discriminate glioscarcomas from other tumors. Believing that such a coherence could hide
strong biological meanings we focused on gliosarcomas the efforts to detect emergent properties.
This complex task, that cannot be fully explained with the data and results in hand, can take
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(a) Tumor Grade
High/Low Grade
P High P Low
High 9 0
Low 1 2
p=0.045
(b) Anaplastic
Anaplastic
P Anap P *Anap
Anap 10 0
* Anap 0 2
p=0.015
(c) Glioblastoma
Glioblastoma
P Glio P *GLio
Glio 5 1
* Glio 1 5
p=0.08
(d) Gliosarcoma
Gliosarcoma
P Gsar P * Gsar
Gsar 2 1
* Gsar 2 7
p=0.23
Table 4.5. Performances of Model 3 using only miRNA data. These Tables shows the classification performances
of Model 3 on expression data of miRNA only. Significant classifications in bold (p < 0.05). Anap: Anaplastic;
*Anap: non Anaplastic, Glio: glioblastoma; *Glio: non glioblastoma, Gsar: gliosarcoma; *Gsar: non gliosarcoma.
advantage of intriguing observations emerging from the analysis. We notice, in fact, that the
presence of the sarcomatous element, that derives from an endothelial hyperplasic lesion [FG55],
is a characteristic of these kinds of tumor.
The hyperplasic lesion is a proliferation of vessel-wall components that contains endothelial
cells, myofibroblast, smooth muscle cells and other components of the vascular endothelium
[KTF+86]. In [Men08] it is also shown that cluster miR-17-92 is related to solid tumors an-
giogenesis. The finding of this cluster, and the homologous miR-106-363, in the factor that
contributes to discriminate gliosarcomas, could then indicate an involvement in the develop-
ment of the sarcomatous element.
4.2.4 Identification and interpretation of Simple latent structures
In this Section we present results obtained from analyzing with FA and LDA the two datasets
(mRNA and miRNA) separately. Our original hypothesis dealt with the ability of the complex
analysis to identify emergent properties. To evaluate this hypothesis we produced a 3 factor
model with factor analysis on the two expression matrices separately. Next, we analyzed the
two series of factor scores using separate LDA. In this Section we identify with Fmii Factor
i obtained from the miRNA dataset and with Fmj Factor j from the mRNA dataset (Fk
continues to identify Factor k from the joint dataset. Regarding the identification of the latent
structures, as expected and given the larger size of the mRNA matrix, the results in terms of
discrimination power among tumor classes and the functional analysis are unchanged. However,
the situation is different for the miRNA data.
As shown in Table 4.5 only high/low grade tumors and anaplastic/non analplastic categories
are predicted with the same accuracy (and on the same factor, Fmi2). The accuracy is lower,
0.83 (p = 0.08) versus 0.92 (p = 0.015) for the glioblastoma/non-glioblastoma category. This
occurs because one of the glioblastomas is predicted as a non-glioblastoma. Furthermore, the
discrimination appears to be based on a linear model composed only by Fmi1 and not on a
combination (see F1 and F2 in the complex analysis). The discrimination between gliosarcomas
and its dual class is the worst, as accuracy drops to 0.75 (p = 0.23) and Fmi3 is not used in
discrimination.
For what concerns the interpretation of the latent structures, out of the 18 miRNAs selected,
9 are in common with the joint analysis and 9 represent a new set of miRNAs. Five of the
miRNAs in the new set are associated with biological terms, and only one (hsa-miR-126) is
shared by more than one factor (Fmi1 and Fmi2). Fmi1 contains 5 terms, Fmi2 2 terms (a subset
of Fmi1) and Fmi3 2 terms (Table 4.6). These are related with the regulation of the transcription
(in Fmi1 and Fmi3) and they show some overlap with the mRNAs Factors annotation. Namely,
biological terms in Fmi1 overlap with all the three Fm whereas terms in Fmi2 overlap only with
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miRNA Annotation Factor
hsa-miR-106b response to gamma radiation Fmi1
hsa-miR-29b cell fate determination, positive regulation of gene expression Fmi1
hsa-miR-23a cell adhesion, chemotaxis, positive regulation of
monocyte chemotaxis, extracellular space Fmi2
hsa-miR-126 membrane to membrane docking, cell junction Fmi1, Fmi2
hsa-miR-155 regulation of natriuresis, regulation of cell growth
positive regulation of inflammatory response,
regulation of blood vessel size by renin-angiotensin,
Transcription regulation, Nucleus negative regulation of cell
proliferation, negative regulation of cell proliferation
response to toxin, response to UV,
positive regulation of programmed cell death
cyclin-dependent protein kinase inhibitor activity
nuclear matrix RNA binding, protein binding Fmi2, Fmi3
hsa-miR-210 cell-cell signaling Fmi3
hsa-miR-27a regulation of transcription, DNA-dependent Fmi3
Table 4.6. miRNA from Simple Structure Analysis. Functional Annotation. Only miRNAs that give an anno-
tation are listed in the table. Fmi1: Factor 1; Fmi2: Factor 2; Fmi3: Factor 3. Italics: miRNAs and annotations
shared with the Complex Analysis.
Fm2. Terms in Fmi3 are found both in Fm2 and Fm3. With respect to the comparison to the
complex analysis, since these miRNAs are mostly clustered in homologous factors it is possible
to associate Fmi3 with F1, Fmi2 with F2 and Fmi3 with F1). The miRNAs shared with the
complex analysis and that return an annotation are in Fmi2 (both miR-155 and miR-23a) and
Fmi3 (miR-155).
However, without the joint analysis there is no obvious rationale to associate miRNA factors
with mRNA factors. This is because, crucially, the 18 miRNAs obtained are distributed over
factors that are decoupled from the factors returned from the simple mRNA data analysis.
Therefore this approach does not suggest any obvious association between the two sets of
factors. As a consequence, the interpretation of this latter (simple) analysis is limited to the
indirect functional annotation of this small set of miRNA (Table 4.6). Therefore, the activation
of the polycistronic clusters miR-17-92 and miR-106-363 does not emerge when miRNAs are
analysed separately.
In summary, combining the two datasets and applying FA and LDA, provides an obvious
way to associate the translational and post-translational information. In particular, although
the mRNA latent structure is the same in the simple and complex analysis, and consequently
the functional annotation is the same, hidden signals present in the smaller dataset (miRNA
set) appear to be amplified by the signals present in the larger dataset (mRNA set) thanks to
their association in a common latent structure.
4.2.5 Alternative approaches
In order to compare our approach to other likely tools, we choose to analyze the mRNA/miRNA
dataset with 3 methods. First we used hierarchical clustering [ESBB98] an unsupervised and
extremely popular tool for microarray analysis. Given the poor results obtained, we sought to
preprocess the dataset with SAM, another very popular, but supervised method that imposes
a structure in the data according to an a priori classification of the dataset (i.e. grade and
tumor type), to favor the identification of elements related to the clinical classification.
Clustering has been successfully used in the past to classify clinical samples based on mi-
croarray data, therefore the current analysis aims at showing more the inability of this approach
to identify emerging properties (in this case the polycistronic miRNA clusters) rather than its
limited ability to classify samples.
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(a) Sample Clusters (b) Clusters size
Fig. 4.2. Results of Clustering. Figure 4.2(a) shows the sample clusters obtained without preliminary SAM
analysis. Results are identical for the analysis performed after SAM analysis. Figure 4.2(b) shows the variability
in the clusters number around threshold values varied in the interval [0.4-3] for SAM + Clustering analysis.
4.2.5.1 Cluster Analysis R was used to perform clustering on the whole dataset based on
euclidean distance and correlation between each couple of experiments, obtaining two sets of
n(n−1)/2−n = 120 distances. Sample clusters identified two low grade tumours (T21 and T24)
clustered together whereas the third low grade oligodendroglioma (T19) was clustered with two
high grade glioblastoma (T20 and T26). The high grade sample glioblastoma/gliosarcoma (T18)
was clustered with a gliosarcoma (T28). Two subclusters group together samples T22 and T27
and samples T23 and T25 (glioblastoma), respectively. All of these sub-clusters were combined
by the clustering procedure in three clusters: T22, T27, T29, T18 and T28 were assigned to
cluster 1; T23 and T25 to cluster 2 ; T19, T20, T26, T21 and T24 to cluster 3 (see Figure
4.2(a)). In samples clustering we followed the empirical approach that the number of clusters
should be close to
√
n, with n indicating the number of items to be clustered. Observing the
clusters composition, a latent structure in the tumor samples can be hypothesized. To validate
this hypothesis, we used χ2 statistical test to verify if one of the three clusters contained
information on one of the four tumor types. However, no cluster was able to discriminate
significantly (p > 0.05) between tumor classes.
4.2.5.2 SAM R package samr was used to perform a reduction of the dataset on the basis
of the tumors grade (High/Low) and the tool was run with ∆ = 0.3. SAM basically works
as a generalized t-test to identify genes whose average behavior in one class is statistically
significantly different from the one in other(s) class(es). With these settings, SAM returned
a subset of 419 (8.5%) genetic components, of which 413 (8.5%) were Affimetrix ID and 6
(6.7%) miRNAs. The analysis performed on the set reduced by SAM, lead to the same sample
clustering obtained without SAM pre-processing. Distance between the first three samples
(T19, T21, T24), the low grade tumours, is similar to the distance found with clustering alone.
Therefore, even after imposing a structure in the datasets, none of the clusters can discriminate
among classes. It is worth noting that Anaplastic/Non Anaplastic tumours can be identified
(with and without the use of SAM) only if the dendrogram is cut in order to isolate the
subcluster T21, T24. But this approach leads to 7 and 10 clusters with and without SAM
preprocessing, respectively, which, starting from 12 items defeats the purpose of clustering.
Cutoff selection Cutoff threshold for identifying genes clusters was set to 2.1, after visual inspec-
tion of a diminished variability in the clusters number around this value (Figure Figure 4.2(b)).
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Sample Tumor Type C.1 (low/high) C.2 (anapl/non-anapl) C.3 (gliob/non-gliob) (glios/non-glios)
T19 Oligodendroglioma l n ngb ngs
T21 Anaplastic mixed glioma l a ngb ngs
T24 Anaplastic mixed glioma l a ngb ngs
T18 Glioblastoma/Gliosarcoma h n ngb/gb ngs/gs
T20 Glioblastoma h n gb ngs
T22 Glioblastoma h n gb ngs
T23 Glioblastoma h n gb ngs
T25 Glioblastoma h n gb ngs
T26 Glioblastoma h n gb ngs
T27 Glioblastoma h n gb ngs
T28 Gliosarcoma h n ngb gs
T29 Gliosarcoma h n ngb gs
Table 4.7. Tumor Types and Categories. Schematic summary of tumors types used in the experiments, and
category used for the discriminant.
This lead to the identification of 5 clusters composed respectively by 141 (2 miRNA), 164 (1
miRNA), 34 (1 miRNA), 48 (0 miRNA) and 32 (2 miRNA) elements. These clusters were ana-
lyzed to verify if they were significantly enriched in any GO functional category. No functional
terms were found statistically significant.
4.3 Procedure
4.3.1 Dataset
In this work, we applied FA to the dataset from [LPP+07]. These data consist of 12 microarray
samples (for mRNA genome-wide expression, around 14,500 coding genes) and 12 real-time
PCR (for the profile of 93 miRNAs), performed on the same 12 human primary brain tumor
biopsies (details in Table 4.7). On this test case dataset, we first identified the best FA model
(i.e. the appropriate number of factors) based on the model’s ability to explain the relevant
clinical and histopathological information.
Next, we characterized the factors based on 3 properties: 1) their ability to discriminate
among tumor types -this was done using Linear Discriminant Analysis (LDA, [JW02]), a su-
pervised classifier able to find the linear combination of factors which best separates two pre-
defined classes; 2) their functional biological characterization with the help of literature and
databases; 3) their complex biological characterization, by searching novel properties emerging
from the joint analysis of miRNA and mRNAs. The procedure is summarized in Figure 4.3.
4.3.2 Data preprocessing
Data from [LPP+07] were transformed by computing log2 of the intensity value of mRNA
expression (miRNA data come already in log2 from real-time PCR). Quality selection filtering
was performed removing every row (mRNA or miRNA expression across 12 experiments) with
maximum fold change below 2.5; this reduced the dataset from 7,182 IDs to 4.966 IDs. The
filtering was decided to select genetic elements with strong signal of variation. This criterion
was selected as natural consequence of the filtering performed by the authors of the dataset
[LPP+07] that used the same conditions to reduce the number of the IDs. Data were also
normalized in different ways according to:
• xˆ1ij =
xij −mi
Mi −mi , were Mi and mi are the maximum and minimum values in the ith row,
and xij is the expression of gene i on sample j.
• xˆ2ij =
xij −mi
Mi −mi + µi, where µi, is the average expression level in the ith row, and xij is
the expression of gene i on sample j.
The two methods map the expression level in an interval comprised between 0 and 1 the
first and µi and µi + 1 the second (in order to introduce in the model also the difference in
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Fig. 4.3. Schematic view of the complex analysis performed jointly on mRNA and miRNAs from the same 12
tumor samples.
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expression between genes). The two normalizations give identical results in the Factor Analysis
step as expected. In fact, expression signals obtained from qPCR are different from signals
obtained from microarrays due to the extended dynamic range of the former. It is common
[WNK+07, WAC07], in order to validate a set of coding genes obtained by microarray, to
express the mRNA level in each sample as a fraction of the expression level in the sample in
which that mRNA is most abundant. So, from this point on, miRNA and mRNA expression
data were analyzed together, as a single expression table with normalization xˆ1ij .
4.3.3 Factor analysis
The Factor Analysis model is defined in matrix notation as: D = LF + ε, where D(m × n)
represents the data matrix, L(m× l) is the factors loadings matrix, F (l×n) is the factors scores
matrix and ε(m×n) is the unique factors matrix. Furthermore, m are the number of samples, n
the number of genetic elements and l the number of factors. Our model assumes that F and ε are
independent, E(F ) = 0, and Cov(F ) = I. Under these conditions Cov(D) = LLT +Cov(ε), for
the sake of clarity LLT is named communality and Cov(ε) uniqueness. Variability in a human
tumor expression dataset arises from several sources besides tumor type, including human
variability (sex, age, race) and experimental variability (systematic and stochastic errors).
Available information is about tumor types, therefore, our model explicitly involves tumor
types variability, and groups other causes within the ε term, showing the power of the FA
method. In our work, we were interested in discovering the hidden or latent structure within
tumor types, therefore FA is applied using the model D = XT .
The R-package HDMD developed by Lisa McFerrin at North Carolina State University
was used to take advantage of the principal axes algorithm. Communalities were estimated
by iteratively updating the diagonal of the correlation matrix and solving the eigenvector
decomposition. Axes were rotated to simple structure using the Promax algorithm to improve
their interpretability. The simple structure obtained after rotation meets the requirements
proposed by Thurstone [THU46, THU47] to assure the stability of FA results.
The factor score matrix was analyzed for each of the 5 models (from 1 to 5 embedded
factors). The scores associated to the genes within each factor were ranked in descending order.
All 3 factors presented a similar scores distribution with average µ ' 0 and standard deviation
σ ' 0.75. Selection has been performed by looking at the value distribution of each row of matrix
F and then considering as genes associated with a factor only those whose corresponding score
is outside the 2σ interval. In this way, only genes with a strong relation in the same factor were
selected.
4.3.4 Discriminant analysis
The factor loadings coefficients matrix of each model was used to perform LDA. Four dichoto-
mous categories (given by a class and its negate, e.g. glioblastoma/non-glioblastoma etc.) were
defined (Table 4.7). LDA was also performed to assess the most likely class of sample T18
which had an ambiguous classification (glioblastoma/gliosarcoma), see Table 4.8.R-package
MASS [VR02], function lda() configured to perform a classical cross-validation classification
(jack-knife method, also known as leave-one-out validation) was used. In particular we used a
step-wise greedy strategy, i.e. checking performances with one factor, and adding another factor,
iteratively. All possible equivalent combination of factors were tested, and the most performant
with the smallest number of factors involved was chosen.
Particular care must be taken with respect to sample T18, which comes in [LPP+07] with
an ambiguous classification of glioblastoma/gliosarcoma. Gliosarcomas are variants of glioblas-
tomas where the sarcomatous element is mixed with the gliomatous. For this reason we defined
T18 as gliosarcoma, as this appears to add specificity to the glioblastoma histopathological
classification of the sample. However, to disambiguate its definition, and to assess the impor-
tance of this classification in the final results on Model 3, we assigned T18 to both categories
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(a) Tumor Grade
High/Low Grade
P High P Low
High 9 0
Low 1 2
p=0.021
(b) Anaplastic
Anaplastic/*Anaplastic
P Anap P *Anap
Anap 10 0
* Anap 0 2
p=0.004
(c) Glioblastoma
Glioblastoma
P Glio P *Glio P Glio P *Glio
Glio 7 0 6 0
* Glio 2 3 1 5
T18 as Glio T18 as *Glio
p = 0.072 p=0.012
(d) Gliosarcoma
Gliosarcoma
P Gsar P * Gsar P Gsar P * Gsar
Gsar 3 0 0 2
* Gsar 1 8 0 10
T18 as Gsar T18 as * Gsar
p=0.02 p = 1
Table 4.8. Discriminant Analysis on Sample T18. These tables show the classification performances of Model
3 when T18 is classified in 4 different possible ways: Gliosarcoma and dual, and Glioblastoma and dual. Sig-
nificant classifications (p < 0.05 after Bonferroni correction) are shown in bold. Classification performances
are statistically significant when T18 is classified as Gliosarcoma and not as Glioblastoma. Anap: Anaplastic;
*Anap: non Anaplastic, Glio: glioblastoma; *Glio: not glioblastoma, Gsar: gliosarcoma; *Gsar: not gliosarcoma.
and their complement (Gliosarcoma/Non Gliosarcoma; Glioblastoma/Non Glioblastoma) and
then performed the LDA on the 4 different datasets obtained. If LDA is able to correctly
discriminate the known classes, we infer it can also properly assign this ambiguous sample.
As shown in Table 4.8c) and Table 4.8d), LDA performs a better discrimination when
T18 is assigned to the Gliosarcoma class rather than to Glioblastoma. When the sample was
assigned to the category of the Non Gliosarcoma, LDA lost completely the capacity to detect
gliosarcomas in the samples. Conversely, when T18 was assigned to the Glioblastoma class,
LDA assigned 9 samples instead of 7 to Glioblastoma.
4.3.4.1 Alternative Classification Analysis Loading scores contain a signal that a classi-
fier can extract to discriminate between tumor classes. We used 4 standard alternative classi-
fiers: Support Vector Machines, Neural Networks, Naïve Bayes and K-Nearest Neighbor down-
loaded from http://www.patternrecognition.co.za/sourcecode.html. We used the default
parameters to classify the four tumor classes.
4.3.5 Model selection
To evaluate the performances of each factor model on the four tumor classes, we evaluated
the contingency table obtained from the discriminant analysis by Fisher’s exact test. The null
hypothesis assuming that the discrimination between two tumor classes is due to chance was
rejected for p < 0.05. For models with similar prediction scores we kept the one with fewer
factors.
4.3.6 Functional classification
On both FA and clustering (used as alternative method to our approach, see Supplementary
Information) functional analysis was performed using the online tool DAVID [DSH+03, HSL09]
using GO terms, Kegg pathways terms, SP keywords and features and InterPro terms. The
whole list of 4876 probe ID was used as background population. In order to reduce the number
of non significant associations, a resulting functional cluster was further analyzed if and only if
it contained at least one category with Benjamin score < 0.05. The indirect functional analysis
performed to describe miRNAs relevance was performed by searching manually in TarBase
all the known coding genes that are target of the miRNAs identified by the FA and clustering.
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Then for each gene a list with all the associated GO terms was compiled. Due to the small
number of targets obtained no p-value could be associated to any GO term.
4.4 Conclusion
The capability to discriminate between a priori defined classes can be achieved in a variety of
ways (a comparison with supervised and unsupervised algorithms is provided in the Supple-
mentary Information). However, the capacity to generate factors explaining the complexity of
the molecular interactions requires the ability to construct multilevel clusters. With the data
at hand we showed that this cannot be achieved in parallel analysis (versus simultaneous or
joint) of the two datasets (mRNA and miRNA) or with other approaches we evaluated. The
interpretation of factors based on associating them to mRNA/miRNAs represents the ma-
jor contribution of this work. Certainly, the study of [LPP+07] shows sample size limitations
(12 patients enrolled) therefore our analyses must be considered as an exemplar of the factor
analysis approach.
Globally, based on this analysis, since the miRNAs in F3+ belong to two redundant clusters
of miRNA, we can speculate that: 1) one of the biological functions in which these clusters could
be involved is the regulation of the transcription and 2) in some way, in brain tumors these
two clusters are active whereas, in normal cells, only miR-17-92 appears to be constitutively
expressed. Probably both clusters act on the same set of coding genes, but the two loci are
regulated separately in normal cells [LLLR07]. Nevertheless, despite this strong relationship
between the 2 clusters it is difficult to understand how this redundancy works effectively in
cells. However, the finding of a possible activation of the polycistronic genes miR-17-92 and
miR-106-363 represents an encouraging evidence that the factorization of the miRNA and
mRNA data can reveal latent structure in the configuration of the expression levels in tumor
samples.
Despite obvious limitations, we believe our results clearly show that this approach is a very
powerful one for the study of multilevel omic data, which in turn can bring more insight into
understanding the complex mechanisms of the transmission of information in the cell as a
whole.
Chapter 5
Insertion Sites Detection
5.1 Motivation
Gene therapy is a therapeutic approach based on the principle that a defective gene can be
corrected using a healthy gene copy stably introduced into the host. Retroviral vectors which
stably integrate as proviruses into the cellular genome have been successfully applied for the
correction of hematological diseases [CCLHBAF05, Koh08].
From insertion site analyzes of preclinical studies and clinical monitoring of gene modified
hematopoietic stem and progenitor cells in patients it has become evident that biologically
relevant vector induced side effects ranging from in vitro immortalization to clonal dominance
and oncogenesis in vivo accompany therapeutic efficiency of integrating retroviral gene transfer
systems. Analyzing the insertional repertoire of treated patients and newly established thera-
peutical vectors in preclinical animal models has become an important parameter for dissecting
the genotoxic potential of retroviral vectors.
A specific list of risks and limitations could be associated to gene therapy procedures
[BKM+06]. The a-priori probability that an insertion event disrupt a tumor suppressor genes or
trans-activate a proto-oncogene has been considered negligible. Initial reports from the SCID-
X1 gene therapy found that a Murine leukemia Virus (MLV) derived vector was integrated in
proximity of LMO2 proto-oncogene in 2 out of 10 treated patients.
It has been described that in addition to overt carcinogenesis, even as a single vector copy,
many insertion locations more subtly influence the biological fate of a cell clone in vivo. With
LAM-PCR technology [SCS+03, SSB+07] specifically developed for this purpose, it has been
shown that over 40% of circulating cells carry insertions in a rather small set of frequently af-
fected common insertion sites (CIS). Such CIS are almost always in the direct vicinity of known
and novel genes likely involved in cellular growth, survival and self-renewal processes of imma-
ture progenitor and stem cells [HBAVKS+03a, HBAvKS+03b, DHBAS+07, SHS+07]. Insights
into the distribution of retroviral vector integration sites in human gene therapy patients suggest
that most of the insertion loci which are of biological relevance are not located in unchartered ge-
netic territory but harbor a “known suspect” gene waiting to be discovered in the act of distort-
ing cellular survival [HBAVKS+03a, HBAvKS+03b, SCS+03, DHBAS+07, SHS+07, BSS+10].
First analysis of integration sites have been performed using inverse-PCR, LM or LAM-PCR
combined with shotgun cloning and Sanger sequencing [DHBAS+07, ACA+07]. This approach
is expensive, time consuming and low sensitivity with only 100-300 insertion sites per patients.
To overcome these limitations Schmidt et. al [SSB+09] recently introduced a new technique
that, combines LAM-PCR with next generation high-throughput sequencing platforms allow-
ing a comprehensive assessment of vector insertion sites and semi quantitative estimations of
clonal dynamics and hematopoieses by measuring the relative retrieval frequency of individu-
ally retrovirally marked clones following sequencing [GEP+09, PAG+10]. In combination with
optimal restriction motif usage as well as the establishment of a novel non-restrictive LAM-
PCR approach the genomic accessibility to vector insertion sites has further been improved
substantially however sampling error as well as amplification biases can still influence the ac-
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cessibility and quantification of insertion sites making sensitive capturing techniques aimed to
overcome amplification bias highly attractive for clinical monitoring of gen therapy patients.
In this project we aim to establish and optimize a novel high-throughput sequencing strat-
egy for retrieval of insertion sites which is independent of PCR amplification. The capturing
of integrated vector insertion sites using sate of the art array based hybridization steps was
evaluated for further optimization. Hybridization based methods allowing a direct selection
and next generation sequencing of whole integrated vector copies enable the precise analysis of
vector insertion sites as well as true germline configuration and stability of therapeutic vectors
in clinical and preclinical studies. The direct selection of virtually any type of sub genomic
elements followed by next generation sequencing of the genetic information is of high value for
genome and cancer genome characterization. Once proven successful for precisely identifying
vector insertion sites including simultaneous identification of both flanking genomic regions
and whole interior vector sequences such technical platforms can be exploited for analyzing
chromatin marks of integrated vectors and surrounding cellular sequences in combination with
chromatin IP procedures. For evaluating the feasibility of this approach human cell lines, which
were transduced with lentiviral vectors and in which insertion sites have been characterized by
nr-LAM-PCR and 454 sequencing previously, were subjected to direct selection techniques
based on hybridization (FEBIT) and next generation sequencing (SOLiD).
The aim of project was to establish bioinformatical platforms required to filter and resolve
raw sequencing data obtained from the sequencing of captured vector genomes and insertion
sites by the hybcapture method offered by the FEBIT company using specially customized
chips.
5.2 Procedure
5.2.1 Genomic data
Geniom platform (FEBIT; http://www.febit.com/) provide a highly automated enrichment
environment for DNA fragments. The DKFZ team and the FEBIT company developed a biochip
in which each spot is a target for a specific vector’s region. Their customized chips were devel-
oped completely covering the vector by 1 bp spaced 50 mer probes. For maximizing retrieval
of flanking cellular sequences, additional 50 mer probes for the LTR sequences were added so
that close to 47% of the surface spots is covered by 5’ and 3’ vector’s end (Figure 5.2).
Two micrograms of DNA was extracted from a sample of human fibroblasts transduced by
lentiviral vector. The DNA was captured and sequenced ocurding to FEBIT.
5.2.2 Sequencing and filtering procedure
As specified in Sasson et al. [SM10] SOLiD reads are affected by both polyclonal and indepen-
dent errors.
A set of 43,487,758 SOLiD sequencing reads of 50 base length were analyzed accordingly with
a filtering procedure based on the values provided by the SOLiD quality file that reduce noise
in data and computational resources. We used SOLiD_preprocess_filter.pl a PERL script,
provided as supplementary material by Sasson ([SM10], http://hts.rutgers.edu/filter/),
modifying the input parameters (see Table 5.1) in order to reduce the stringency of the filtering
procedure and maintaining the mean quality in all positions reliable (quality value > 20; Figure
5.1).
5.2.3 Align in color space
Based on design and previous characterization of the sample analyzed some expectation on
general results were anticipated. These include the specific retrieval of defined genomic regions
containg known insertion sites in the EPB41L2 and CCR5 gene (personal communication). In a
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SOLiD_preprocess_filter.pl -f sample.csfasta -g sample.qual -q 20 -e 6 -o outputFile
Table 5.1. Parameters used to filter the SOLiD reads. -f: csfasta file for the forward strand; -g: quality file for
the forward strand; -q: polyclonal analysis minimum QV score (default 25); -e: the maximum number of errors
allowed per read (default 3); -o: prefix of the output files name.
Fig. 5.1. SOLiD quality plot after filtering procedure. As expected the quality decrease in the terminal portion
of the reads but maintaining a good median quality (24 in position 48 and 50).
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Fig. 5.2. FEBIT capturing method. The whole vector is represented on the biochip with a preference for the
LTR external portions. This design bias is expected to be highlighted counting the number of reads along the
vector.
first step the reliable set of reads was aligned to the vector expecting that most of the coverage
was detected on the boundary.
For this stepMosaik was used (see Table 2.3) which contains an option that permits to align
SOLiD reads in color space via previous conversion of the target in color code. Is important
to note that the two most important regions for defining insertion sites based on identification
of clear vector-cellular boundaries, the so called Long-terminal-repeats of the vector (LTR, see
Figure 1.3), are identical in sequence masking the mapping of the vector fragment to the 5´-
or 3´-LTR. This limitation was overcome by introducing a string of neutral “N” symbols from
the base 100 to the base 234 and from the base 3,711 to the base 3,844.
As mentioned MosaikAligner was used for both vector and genome alignment. Program
parameters are selected on the basis of the considerations in 5.2.3.11.
5.2.3.1 On the reads length Here we faced for the first time with the main challenge that
affect the design of the project: the length of the reads. Usually, one of the steps involved in
high-throughput insertion sites detection is the trimming of vector and link sequences from the
hybrid2 reads in order to obtain only the genomic fragment that is used for genome mapping
1parameters: : -hs 5 -mm 0 -mhp 100 -act 6 -mmal -minp 0.3
-hs: hash size
-mm: maximum mismatch threshold
-mhp: hash position threshold
-act: alignment candidate threshold
-mmal minp: minimum percent alignment threshold
2When a read contain both genome and vector sequence we call this read hybrid.
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Fig. 5.3. Vector-Cellular junction. The vector portion is removed from the read and the flanking region is
aligned and annotated on the target genome.
and thus retrieve information on the targeted loci (Figure 5.3). Because the kinetic complexity
of the vector is 4,000 bp3 we could imagine that is possible to map uniquely the vector using
only sequences with length 6(4). We used this characteristic to set the aligner’s parameters. The
complexity of the human DNA, used to query the Geniom Biochip, is about 3 · 108 taking into
consideration only the slow kinetic component. We expect by chance, under these assumption
and under a simple uniform model, more than 1 match if the query sequence is 14 bases-long.
Considering that the vector “generate” 4,000 different strings we need a match composed by
at least 20 bases5 to have a probability equal to 1/4000 ≈ 0.00025 to retrieve random match
when the kinetic complexity is comparable with our data. Therefore if the sequence has a total
length equal to 50 both the genomic and the vector ends must be composed at least by 20
bases.
5.2.3.2 Vector mutation The Geniom Biochip is designed to contain about 1Mb of target
region and guarantee high coverage (http://www.febit.com/microarray-sequencing/). The
SOLiD color code in combination with high coverage is useful for SNP calling. We exploited
this feature to: 1) check the global technical quality of the experiment and 2) detect eventual
mutations appeared on the vector.
The captured target region is relatively small (about 4000 kb) expecting us to obtain a very
high coverage. The organization of the vector on the chip is asymmetrical because biologists
decided to use the 47% of the synthesis space for 500 bases that belong to the two ends of the
vector and the remaining 53% for the other 3450 bases. The awaited coverage ratio between
the two chip areas is computed as R = 0.450.55
3450
500 ≈ 6.25.
Browsing literature and the FEBIT web site, we found a published paper [SWH+09] and
some reports where the mean coverage and the target region length for four experiment are
described (Table 5.2 ). From this data we could compute the expected mean coverage on our
vector. Giving a first target region with known dimensionT1 and coverage C1 and a second
target region with known dimension T2, the unknown coverage C2 can be calculated using the
equation C2 = C1 T1T2 . The upper bound for the coverage in our data is 125,000 on average,
assuming that all the selected reads align with the vector (Table 5.2).
Mutations in the wild type retroviral genome are readily introduced and my occur at differ-
ent sages of the viral replication cycle. Retroviral based vectors are defective in replication and
only produce a single round of integration, however mutations may still be introduced during
reverse transcription and cellular replication effecting stability of vector genomes. Due to the
fidelity of cellular DNA replication (10−9 to 10−11 substitution per base pair), it is unlikely
that mutations occurring during cellular replication of the provirus contribute significantly to
3An approximation based on that the vector contains only unique sequences gives a complexity that is equal
to the length (≈ 4Kb).
44000 ≈ 212 = 46.
520 bases generate a sequence space of 240 sequences. The number of expected matches when the alignment
is 20 bp, the target is 4000 bp and the complexity of the query is 3 · 108 bp is
3 · 108 4 · 103
240
≈ 1
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Case study Coverage (C1) Target (T1) Expected Coverage (C2)++
1∗ 402 498 Kb 50,049
2+ 176 482 Kb 21,208
3+ 2388 160 Kb 95,520
4+ 1336 160 Kb 53,440
Table 5.2. Reported coverage for some experimental results. ∗ From [SWH+09] ; + from
http://www.febit.com/;++ considering the target dimension equal to 4000 Kbases.
1 2 3 4 5 6 7 8 9 10
XYZ 1001 A A 11 0 15 3 ..c II
XYZ 1002 C C 75 0 25 6 ...,., III2
XYZ 1003 T A 255 238 255 6 a..aa., III7
XYZ 1004 G G 255 0 255 5 ...... III1
Table 5.3. 10 columns MAQ model explanation. 1 Reference name; 2 position; 3 reference base at that position;
4 consensus bases; 5 consensus quality; 6 mutation quality; 7 maximum mapping quality; 8 coverage (# reads
aligning over that position); 9 bases within reads where; 10 quality values (phred33 scale, see Galaxy wiki for
more).
the high degree of vector diversity. Therefore, most mutations are introduced during reverse
transcription and/or RNA pol II transcription of the provirus. In our experiment the last pos-
sibility is not a source of variation due to the defective nature of the vectors used in gene
therapy
The analysis of the coverage on the vector sequence could reveal (with the coverage expected
in Table 5.2) mutations with a high degree of confidence. The analysis started using the resulting
alignment file converted in BAM format (using MosaikText 6). Then SAMtools [LHW+09]
is used to generate a pileup file according to Maq model [LRD08]. The pileup file is a flat file
where each row represents a position on the reference sequence (the vector sequence) and the
columns represent information shown in Table 5.3 on that location . Columns number 2,4,6
and 8 that represent position, variation, mutation quality and coverage respectively, are used
to filter out mutations. The deep of the coverage is really high and a considerable fraction
of positions contain significant mutations with MAF < 0.01. For this reason we decided to
increase the stringency and to report only mutations where the MAF is more than 0.01.
5.2.3.3 Align on Genome The human genome was converted in color space using Mosaik-
Build in order to map the hybrid reads obtained aligning the vector. Then the alignment was
converted in a tabular SAM format and checked for the Hypothetical insertion sites found on a
local version of the Ensembl Genes version 59 (http://www.biomart.org/biomart/martview).
5.2.4 Align in base space
Although contiguous errors will arise from a single color sequencing error when the sequence
is decoded before the alignment, we decided to remove the constrain imposed from the coding
nature of the SOLiD reads and to translate all the reads in base code (Figure 5.4 ).
5.2.4.1 Capture hybrid sequences Then we used a simple script that search, via regular
expression, the first l bases of the vector (the pattern; Figure 5.5) . Vector bases are then
trimmed and the remaining portion of the read is a candidate to detect the target genomic
region. The dimension of the pattern search window was selected on the basis of the consider-
ations in 5.2.3.1 and after an heuristic exploration of the l parameter space. This exploration
6parameters: -in alignmentName -bam outBamName
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Fig. 5.4. awk conversion script between SOLiD color code and base space. The conversion matrix klein.txt
has this structure
 A C G TC A T G
G T A C
T G C A
 . The script uses the the color code at the position i and i − 1 as hash
code to address the base in the matrix. It translate about 87 Mb per minute per CPU.
Fig. 5.5. Diagram for reads selection in base space. First the pattern is searched and then trimmed.
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Fig. 5.6. Effect of pattern length l on the number of matches. D is a sample of m-long reads, that contains
vector sequence starting from position i (where i = 1..m) and R is a sample that do not contain vector sequences.
Under the uniform random model, r = mN(D+R)·4−l is the number of sequences extracted by chance using the
first l characters of the vector, where N(•) return the number of reads contained in a dataset. If the distribution
of the starting points of the vector is uniform in D we could assume that the number of reads extracted from
D is vn = (1 − l−1m )N(D). Using these relation we can compute the expected number of observations in a
mixture model using in this equation v = r+vn = mN(D+R)4−l+N(D)(1− l−1m ). Is also possible to compute
the expected ratio r/v using the rearranged equation r
v
= 1
1+N(D)(m−(l−1))
m2N(D+R)4−l
. In A three sequences are hybrids
sequences (vector in red) and one is random.The length of each read is 40. In B are listed all the possible
patterns from the vector with a window that vary from 1 to 6 bases. As is shown, despite the small sample, the
observed r/O and the expected ratio r/v follow the same behavior. The numbers over the sequences flag which
is the pattern that match on that position.
provides to count the number of the reads returned from the “capturing” procedure varying l
from 4 to 20 with step 2. The idea is based on the assumption that the increment of the num-
ber of bases in the pattern return a number of reads that decrease 1) exponentially when the
pattern is too short and 2) linearly when the pattern length is sufficient to detect non random
hybrids (see Figure 5.6 for explanation). With this model in mind we plotted the number of
reads returned versus the corresponding l; then a minimum width was selected manually where
the behavior of the graph translate from exponential to linear (l = 10 in our case, Figure 5.7) .
5.2.4.2 Align on genome The set of reads that contains (trimmed) terminal portion of the
vector are aligned on the human genome (version hg19) using megaBLAST [AMS+97] that is
fast, reliable and do not require quality values to align sequences. The selection of the alignment
parameters was a compromise between the need of insertions site and the reduction of noise.
As discussed in 5.2.3.1, at least 20 bases are required to target a unique site in the human
genome for most of the alignments. A word size with length equal to 16 guarantee that pieces
of putative genome have a seed sequence that has a perfect match with al least 16 bases of the
query (the read). Then the expected value was set to 1 10−7 and the identity score to 90%.
Whit this setup megaBLAST discard reads that are to small or with an excess of mismatch
and return a set of calls that are good candidates to be real insertion sites.
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Fig. 5.7. Pattern length selection graph. When l > 10 the the exponential behavior (random selection) is
negligible.
Before the “functional” annotation we filtered out reads that map in more than one location
on genome with the same score using a python script developed for this purpose.
5.3 Discussion
From the starting population composed by 43,487,758 reads 10,911,004 of them (25%) passed
the filtering procedure. A previous analysis, with the filtering procedure and default parameters,
returned less than 6 million of reads (1/7 of the entire set) . For this reason we decided to modify
the default parameters due to their excessive stringency. We think that our setting is a good
compromise to obtain a data set with high Signal to Noise ratio but where sensitivity is not
compromised.
5.3.1 Vector alignment
The alignment procedure on the vector was fast, due to this small length, allowing fine tuning
of the parameters and minimizing the number of failed hash code. Theoretically with 6 bases
all the possible configuration of a vector are correctly sampled; due to unavoidable sequence
redundancies in the vector we found that using a hash code composed by 5 elements the number
of unique reads mapped reached a maximum of 3,188,420.
At this point we verified: 1) if the coverage obtained was in the same order of magnitude
of the expected coverage in Table 5.2 (the expectation interval goes from 21,208 to 95,520); 2)
if the distribution of the coverage on the vector is similar to the coverage which should results
from the chip design. The coverage distribution is reported in Figure 5.8.
The observed average coverage (26,189) fall in the low portion of the interval and shows that
our raw results are in agreement with previous findings although a bit less. One explanation for
this attenuation is the filtering procedure that discard 1/4 of the reads and reduce the coverage;
but also the capture method or other factors could be responsible for this phenomenon.
The coverage distribution ratio R between the LRT and the internal vector regions is 4.3
whereas the expected one is 6.25. This ratio has a value that is a little bit lower than expected.
The first explanation is that the area of the chip covered by the vector ends is 38% (instead
of 47%) and the second explanation is that the efficiency of the capturing method was not
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Fig. 5.8. Coverage and Start Site distribution on vector. The two holes at the beginning of the 5LTR and
3LTR are a artifact due to the introduction of “N“ symbols in the vector sequence to avoid conflict during the
alignment.
Fig. 5.9. Raw and filtered vector mutations. Black 45 degree lines: 5’LTR from position 1 to 100; Black -45
degree lines: 3’UTR from position 3846 to 3945; red crossed 45 degree: internal sequence from position 235 to
3710. * position from 101 to 234 and 3711 to 3845 (with ’N’ letters) are removed from the picture. In the LTRs
no mutations are detected.
uniform on the vector. We lean for the second explanation because the first means improbable
errors in chip design and/or probes synthesis.
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Fig. 5.10. Mutation matrix example. Green rectangle: “master” base; blue rectangle: “slave” base; red rectangle:
wrong expected “master” base at position p+ 1; arrows: expectation step between position p and p+ 1.
5.3.2 Mutation detection
In total we found 99 point mutation that occur all over the vector length except in the LTR
regions with a mutation frequency that correspond to one mutation every 40 bases. As is
shown in Figure 5.9 the ratio between the consensus and the target base (MAF) increase
along the first part of the vector; most of the mutations cluster together and only 1/3 of them
are not in cluster. The absence of mutations in LTR is explainable on the fact that mutated
LTR are most likely not functional in terms of the integration reaction catalyzed by the viral
Integrase gene, producing vectors that are defective for the integration. Cluster of mutations
are a phenomenon which hide a more profound significance. One explanation could be that
some positions are preferred mutation hot spots in the vector but this needs to be analyzed
more deeply by comparing mutation hot-spots in the vector in biological replicates.
A second explanation lie on how the SOLiD sequences are aligned on the vector. To under-
stand our point we need to introduce a behavior observed in the mutation matrix that contains,
for each position of the vector, the number of reads that have an “A” a “C” a “G” and a “T”.
We realized that is possible to predict the next base in the sequence simply observing the bases
frequency. Giving the position p the base with the bigger frequency, the “master” base, is the
actual base and the second biggest one, the “slave” base, will be the consensus base in p + 1.
This behavior is a source of noise because when the frequency of the slave base is high or
a region is covered with high quality reads, the mutation caller program detect one or more
mutations where no mutation is present (Figure 5.10).
We exploit this comportment developing a program that predict the base p + 1 and flag
those position where the expected base in p + 1 differ from the observed one. This script and
the mutation caller combined together discard all those mutation that are predictable on the
basis of our model.
In Table 5.4 are listed 16 vector variations that come from the combined filtering strategies.
A deeper analysis in the significance of these mutations will be necessary in order 1) to under-
stand the source of this deterministic behavior and 2) to see if some of them could modify the
vector functionally.
5.3.3 Genome alignment
5.3.3.1 In color space All the 3,188,420 reads that map on the vector were parsed to keep
the hybrids that start on the first or on the last position of the vector (438,504; 13.8%). The
mapping on the human genome (hg19) was done with MosaikAligner7 aligning 7,496 (1.7%)
reads in 4 minutes. Each mapped position was joined with the human genes positions in order to
detect potential genes that are involved in the integration process. Most of the reads correspond
to intergenic regions and only 66 insertion sites fall in gene regions (36 genes), giving less than
2 insertion sites per gene on average. This result was not satisfactory for two main reasons: 1)
7parameters: -hs 15 -mm 2 -mhp 100 -act 20 -mmal -minp 0.3 (see Note 1)
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Position Vector Base Consensus Base
253 c t
949 c g
1186 t a
1187 a g
2001 g c
2383 t g
2580 g a
2815 t c
2816 c g
2818 a g
2820 g a
2821 a c
3180 t c
3189 t a
3409 a c
3672 c g
Table 5.4. Vector Mutations.
in the gene list do not appear EPB41L2 and/or CCR5 and 2) the number of insertion sites
detected by this methods is undersized. Certainly, with the length of our reads we expected
that the sensitivity was lower than the sensitivity of the LAM-PCR but this result did not
mach our quality criteria and for this reason we undertook the way that perform all the steps
in base space.
5.3.3.2 In base space As described in 5.2.4.1 after the translation of 10,911,004 reads in base
space more than 138,000 reads were selected (in the forward direction) and trimmed. These set
was aligned against the human genome using megaBLAST8 and the result, 179,976 positions,
was filtered in order to maintain only reads with unique mapping. The 161,541 unique reads
were further filtered to keep only the alignments in which the first base involved in the match
was the base at position 1. This last step provided 106,796 potential flanking regions found in
the human genome.
More than 80,000 (75%) sites fall in 79 genomic regions. In Table 5.5 the genes are sorted
on the calls (number of insertions sites). The first two position are occupied by EPB41L2 and
CCR5 with 79,046 and 821 calls respectively.
5.4 Conclusion
The performance of the methods that manage sequences in base space worked better. This is
disputable since literature and technical papers warn researchers involved in SOLiD technology
to avoid to decode color reads before the alignment. Our findings are probably explained con-
sidering that SOLiD system works better in SNP detection, when one base mutation leads to
two contiguous color changes, but not when one read contains two kind of sequences of which
one is necessary to select the read and the second to map it on a genome. Furthermore one
color code sequence could potentially align with 4 different target without mismatch (more if
mismatches are allowed); so when the color code reads are small as in our case, most of the
alignments are due to wrong mapping.
As a control we inspected manually a small sample of the aligned reads in color code. The
idea was to check if the decoded read match the portion of the gene detected by the read.
The result of this test was instructive: no one of the read contains the found gene fragment.
8parameters: -a 8 -W 16 -p 90.0 -e 0.001.
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Gene Name Calls
EPB41L2 79,046
CCR5 821
ZCCHC14 625
EYA4 19
CCR2 9
MREG 7
PECR 7
FER 6
SUV420H1 5
Others 77
Total 80,622
Table 5.5. Genes in which insertion sites have been found. In table are reported only genes with more than
4 calls; genes with less than 4 calls are: OCIAD1, HIPK2, IL1RAPL2, PDE11A, PGM5P1, UNC5D, WWOX,
ALAS2, AOAH, BYSL, C1orf175, C20orf185, CACNA2D3, CDH13, CSRNP1, DHDH, DPP6, FAF1, FAM135B,
FAM180A, FBN1, FBP1, GNG12, GOPC, GPR39, GUCY1A3, IFLTD1, ITGA6 IWS1 KLHL22, LRTM1,
MACF1, MCART1, MEAF6, NPHP1, P4HA2, PDE1C, PDE4B, PDE4DIP, PFN2, PGM5P2, PHACTR2,
PINX1, PLCG2 PPOX PTPN4, RAB11FIP1, ROS1, RPE, RUNX3, SAMD3, SCARF2, SGCZ, SGPP2,
SLC15A5, SLIT3, SMOC2, SNTG1, SOX7, TMEM104, TNS3, TRAC, TRBC1, TRERF1, TRPV3, USH2A,
VPS13B, WDR72 and XPO6.
On converse when we coded the gene sequence in color code, partial matches are found. These
findings indicating that the alignment in color code of short sequences could give wrong results.
As expected by the design of the vector, integration sites in EPB41L2 were found more
frequently than the others and, although CCR5 is found with a strong signal, the number of
total insertion sites detected is 2 orders of magnitude less than the integration sites obtained
by LAM-PCR. This means that the sensibility of the method is low and that other strategies
must be chosen in order to reach performances that make direct sequencing approach attractive.
While the selection strategy of the library sequence could be matter of discussion we can assert
that the sequencing technology must provide long reads in standard fasta format.
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Appendix A
R Bus package
In this appendix I show a side work that I contibuted to develop during my stay in Shanghai
and that ended with the release of a R package (downloadable from Bioconductor http://
www.biocontuctor.org)
The number and type of data support produced by innovative biotechnologies to screen
molecular biological data expands very rapidly. Indeed, it is currently possible to observe the
activity (over- under- expression, presence or absence of mutations) of virtually all the molecules
of a given type (mRNA, miRNA, DNA) in one single screen, through high-density chips ,
or via sequencing related techniques. Due to the different biogenesis of these molecules and
to the different technologies behind their screening, preliminary analyses require customized
procedures. However, once the data are processed, their structure can be reduced to a large
tabular format, which rows represent molecules’ activity (over- or under- expression for mRNA
and miRNA data, presence or absence of mutations for DNA data), and columns represent
experimental conditions, a format familiar to the users of microarrays for gene expression, the
earliest high-throughput molecular chips.
The computation of statistical significance is an extremely common task, which has chal-
lenged researchers in particular for the computation of the corrections necessary in case of
multiple hypotheses tested at one time. Given the ubiquitous nature of the operation and of
the data that require it, it is necessary to provide formulas for the achievement of this goal which
encompass the necessity to have large computing facilities only seldom available in biological
lab, which may nevertheless require these computations.
Our package deals with this issue, and offers p-value based statistical significance scores,
focusing on minimizing the number of permutations. Our approach allows to perform with
enhanced and efficient statistical approaches two very common operations (computation of
similarity among genes and computation of similarity of genes with other traits) using correla-
tion and mutual information.
BUS Vignette
Yin Jin, Hesen Peng, Lei Wang, Raffaele Fronza, Yuanhua Liu and Christine Nardini
1 Introduction
GOAL: The BUS package allows the computation of two types of similarities (correlation [Sokal, 2003] and
mutual information [Cover, 2001]) for two different goals: (i) identification of the similarity among the activity of
molecules sampled across different experiments (we name this option Unsupervised, U), (ii) identification of the
similarity between such molecules and other types of information (clinical, anagraphical, etc, we name this option
supervised, S).
Unsupervised Option. The computation applies to data in tabular form (MxN) where rows represents
different molecules (M), columns represents experiments or samples (N) and the content of the tables’ cells the
abundance of the molecule in the sample. Microarray experiments are the data of choice for this application, but
the method can be applied to any data in the appropriate format (miRNA arrays, RNA-seq data, etc.). The
results are in the form of an MxM adjacency matrix, where each cell represents the association computed among
the corresponding molecules. This matrix has associated also a p-value matrix and a corrected p-value matrix (see
below for details). Based on the cutoff selected, the adjacency matrix can be trimmed and lead to a predicted
network of statistically significant interactions (pred.network). This output can be used as-is to represent a
gene association network ([Margolin, 2004, Basso, 2005]), or can be further elaborated to cluster genes based on
a shared degree of similarity (hence the Unsupervised label). Mutual information (from now on MI) is computed
using the minet package [Meyer, 2008], all the options can be found in the corresponding vignette. Here argument
net.trim decides which function (mrnet/clr/aracne) in MINET package is used to give the similarity based on
mutual information matrix. Correlation is computed using the R built-in cor function.
Supervised Option. For the S option a second dataset is necessary, a TxN table, where T represents the
number of external traits of interest. The result is an association MxT table where each cell indicates the association
between the molecule and the external trait. Mutual information is computed according to the empirical method
proposed in MINET package. It is implemented with a external c function. This matrix has associated also a
p-value matrix and a corrected p-value matrix (see below for details). As this can be used to associate samples to
clinical classes we call this option Supervised (this type of approach was used in [Diehn, 2008]).
Statistical Significance. The package offers the possibility to evaluate the statistical significance of the
computed similarity measures in two steps, a summary of the options is given in Table 1.
Option
p-value
single multiple
ρ MI MI
S
Exact beta distribution
permutations (3 options)
U permutations
Table 1. Summary of the available options for statistical validation in BUS. ρ indicates correlation.
First, it allows the computation of the ”single” p-value, i.e. the p-value relevant for the assessment of the
statistical significance of the similarity of a given gene as if it was the only one tested.
For correlation this relies on the R built-in cor.test and it then computes the exact p-value.
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For MI it is obtained from permutations and this method estimates the extreme p-values (close to 0) by fitting
a beta distribution, whose analytical expression is obtained by the estimate of 2 shape parameters (αˆ and βˆ) using
the method of the moments.
Second, for the p-value of MI, correction for multiple hypothesis testing is computed based on permutations. 3
types of corrections are offered:
• S analysis option method.permut = 1 correction for multiple traits tested
• S analysis option method.permut = 2 correction for multiple genes tested
• S analysis option method.permut = 3 correction for both traits and genes
Missing Data Treatment. Data are pre-processed to cope with missing information (both in the MxN and
in the TxN table) using (smooth) bootstrapping [Silverman, 1987].
The main function BUS has arguments for:
• the type of analysis (supervised/unsupervised)
• the distance metric (correlation/MI)
• the correction types for statistical significance on multiple hypothesis testing based on permutations (genes,
traits or both)
Expected computation times. In the unsupervised case, the anticipated time for a 50*12 matrix (gene
expression data) is 30 seconds when running on an ordinary personal computer (with 1G memory). While in the
supervised case, with 50*12 gene expression data and trait data involved, it is 2 minute when correction of both
genes and traits is considered.
The functions’ dependencies scheme of the BUS package is illustrated below.
Figure 1. functions scheme
Functions Description
BUS: A wrapper function to compute (i) the similarity matrix (using correlation/MI as metric) and the single
p-value matrix (each element is the p-value under the null hypothesis that the related row gene and column gene
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have no interaction), corrected p-values matrix (different levels of dependency are considered) and the predicted
network matrix (predicted gene network, this output is effective for option U)
gene.similarity: Function for the computation of the adjacency matrix in the Unsupervised option (using
correlation/MI as metric)
gene.trait.similarity: Function for the computation of the similarity matrix in the Supervised option (using
correlation/MI as metric)
gene.pvalue: Function for the computation of the p-value matrix for the Unsupervised option. Single p-value
(each element is the p-value under the null hypothesis that the related row gene and column gene have no inter-
action) is computed thanks to: (i) for MI the distribution identified by the P permutation values identified for
each gene, with extreme p-values computed fitting a beta distribution; for correlation using the exact distribution
provided by the built-in R cor function (single.perm.p.value). Corrected p-value is computed thanks to the distri-
bution identified by the p permutation values across all genes (multi.perm.p.value). When correlation is used as
matric, only exact p-value is output.
gene.trait.pvalue: Function for the computation of the p-value matrix for the Supervised option. Single
p-value (each element is the p-value under the null hypothesis that the related row gene and column trait have no
interaction) is computed thanks to: (i) for MI the distribution identified by the P permutation values identified for
each gene, with extreme p-values computed fitting a beta distribution; for correlation using the exact distribution
provided by the built-in R cor function (single.perm.p.value). Corrected p-value is computed thanks to the
distribution identified by the P permutation values across all genes (multi.perm.p.value); (ii) the distribution
identified by the P permutation values across all traits; (iii) the distribution identified by the P permutation values
across all genes and traits.
pred.network: Function to predict the network from the selected corrected p-value matrix, only for the Unsu-
pervised option.
2 BUS Usage
> library(BUS)
> library(minet)
> data(copasi)
> mat = as.matrix(copasi)[1:5, ]
> rownames(mat) <- paste("G", 1:nrow(mat), sep = "")
> BUS(EXP = mat, measure = "MI", n.replica = 400,
+ net.trim = "aracne", thresh = 0.05, nflag = 1)
$similarity
G1 G2 G3 G4 G5
G1 1.0000000 0.4682614 0.5126417 1 0.0000000
G2 0.4682614 1.0000000 0.0000000 0 0.7451189
G3 0.5126417 0.0000000 1.0000000 0 0.6168879
G4 1.0000000 0.0000000 0.0000000 1 0.0000000
G5 0.0000000 0.7451189 0.6168879 0 1.0000000
$single.perm.p.value
G1 G2 G3 G4 G5
G1 0.0000 0.2075 0.2450 0.0000 0.5050
G2 0.2075 0.0000 0.4650 0.4775 0.1675
G3 0.2450 0.4650 0.0000 0.4500 0.1575
G4 0.0000 0.4775 0.4500 0.0000 0.4825
G5 0.5050 0.1675 0.1575 0.4825 0.0000
$multi.perm.p.value
G1 G2 G3 G4 G5
G1 0.0000000 0.14494265 0.1305556 0.0000000 0.40182009
3
G2 0.1449426 0.00000000 0.3997930 0.4031812 0.04763561
G3 0.1305556 0.39979303 0.0000000 0.4017271 0.09482459
G4 0.0000000 0.40318119 0.4017271 0.0000000 0.41155989
G5 0.4018201 0.04763561 0.0948246 0.4115599 0.00000000
$net.pred.permut
G1 G2 G3 G4 G5
G1 1 0.0000000 0 1 0.0000000
G2 0 1.0000000 0 0 0.7451189
G3 0 0.0000000 1 0 0.0000000
G4 1 0.0000000 0 1 0.0000000
G5 0 0.7451189 0 0 1.0000000
The arguments to the BUS function here are
• EXP, a matrix for gene expression data.
• measure, metric used to calculate similarity. There are two choices, MI and corr. We use MI here, applying
the MINET package to output the similarity matrix with option of aracne.
• method.permut, a flag to indicate which method is used to correct permutation p-values. Here a default
value (2) is used.
• n.replica, number of permutations: default value is 400, for optimal precision in p-value computation.
• net.trim, method chosen to trim the network. Here aracne method is applied, where the least significant
edge in each triplet is removed.
• threshold, threshold, according to which significant association between genes are selected to construct
the predicted network. This option is acutually used in function pred.network for predicted network from
p-value matrix.
• nflag, a flag for the type of analysis. If Supervised nflag=2, if Unsupervised nflag=1. Here an Unsupervised
option is considered.
The copasi dataset is taken from Copasi2 (Complex Pathway Simulator), a software for simulation and analysis
of biochemical networks. The system generates random artificial gene networks according to well-defined topo-
logical and kinetic properties. These are used to run in silico experiments simulating real laboratory micro-array
experiments. Noise with controlled properties is added to the simulation results several times emulating mea-
surement replicates, before expression ratios are calculated. This series consists of 150 artificial gene networks.
Each network consists of 100 genes with a total of 200 gene interactions (on average each gene has 2 modulators).
All networks are composed of genes with similar kinetics, the only difference between networks is how the gene
interactions are organized (i.e. which genes induce and repress which other genes). The networks belong to three
major groups according to their topologies: RND stands for randomized network, SF for scale-free(many edges
among few nodes) and SW for small world (edges exist between adjacent nodes). The data given in the package
is an RND data. Actually, only first of five rows in the gene expression data is used to calculate to save the space
here.
Explain the results:
• similarity: the matrix for mutual information.
• single.perm.p.value: the single p-value matrix, i.e. the p-value matrix obtained by the simple purmutation
method. We can see it is a 5*5 matrix here as we only use data for 5 genes.
• multi.perm.p.value: the corrected permutation p-value matrix, i.e. the p-value matrix obtained via cor-
rected permutation method.
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• net.pred.permut: the network predicted based on the corrected permutation p-value matrix. This network
is based on multi-hypothesis-corrected p-values.
This is an Unsupervised case. We could see that a lower values in single.perm.p.value/multi.perm.p.value
or a higher values in net.pred.permut indicate a strong link between the row and column genes. The value 0 in
the p-value matrix or 1 in network matrix respectively infers a strong link.
> data(tumors.mRNA)
> exp <- as.matrix(tumors.mRNA)[11:15, ]
> rownames(exp) <- rownames(tumors.mRNA)[11:15]
> data(tumors.miRNA)
> trait <- as.matrix(tumors.miRNA)[11:15, ]
> rownames(trait) <- rownames(tumors.miRNA)[11:15]
> BUS(EXP = exp, trait = trait, measure = "MI",
+ nflag = 2)
$similarity
hsa-mir-132 hsa-mir-133a hsa-mir-135a
200017_at 0.6000000 0.4754888 0.4754888
200018_at 0.2000000 0.5509775 0.4754888
200022_at 0.4754888 0.5509775 0.0000000
200023_s_at 0.0000000 1.0000000 0.0000000
200024_at 0.4754888 0.5509775 0.0000000
hsa-mir-135b hsa-mir-139
200017_at 0.4754888 1.0000000
200018_at 0.4754888 0.4754888
200022_at 0.0000000 0.4754888
200023_s_at 0.0000000 0.4754888
200024_at 0.4754888 0.4754888
$single.perm.p.value
hsa-mir-132 hsa-mir-133a hsa-mir-135a
200017_at 0.2125 0.3700 0.3725
200018_at 0.6175 0.2975 0.4025
200022_at 0.3850 0.3250 0.6700
200023_s_at 0.7225 0.0000 0.7350
200024_at 0.3675 0.3200 0.6900
hsa-mir-135b hsa-mir-139
200017_at 0.3400 0.0000
200018_at 0.4075 0.3600
200022_at 0.7350 0.3450
200023_s_at 0.7075 0.3850
200024_at 0.3875 0.3575
$multi.perm.p.value
hsa-mir-132 hsa-mir-133a hsa-mir-135a
200017_at 0.2435 0.3605 0.3730
200018_at 0.6210 0.3175 0.3730
200022_at 0.3780 0.3175 0.7005
200023_s_at 0.6955 0.0000 0.7005
200024_at 0.3780 0.3175 0.7005
hsa-mir-135b hsa-mir-139
200017_at 0.3805 0.000
200018_at 0.3805 0.357
5
200022_at 0.7060 0.357
200023_s_at 0.7060 0.357
200024_at 0.3805 0.357
Here is a Supervised case, we use the tumor dataset from [Liu, 2007], the mRNA data as gene expression data
and miRNA data as trait data. Gene expression data were obtained by microarray from human brain tumors,
while miRNA data were obtained by RT-PCR. 12 brain tumors at different levels are analyzed for both mRNA
and miRNA levels to study the correlation of any mRNA-miRNA pairs. Outputs are similar like that in the
unsupervised case except the predicted network.
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